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The radical S-adenosylmethionine (SAM) enzymes represent a large class 
enzyme that catalyzes a wide range of reactions, including chemically challenging 
reactions in critical pathways across all domains of life. Work here describes the detailed 
mechanistic studies of three of these enzymes in unusual methylation, ring cleavage, and 
rearrangement reactions. 
CysS is a cobalamin-dependent radical SAM methyltransferase that catalyzes the 
iterative methylations on the 3-methoxy-4-aminobenzoic acid moieties of the antibiotic 
cystobactamids. We were able to reconstitute the activity of CysS in vitro and 
demonstrate that it can catalyze sequential methylations from a methyl group to form not 
only ethyl, isopropyl groups but also sec-butyl, t-butyl groups by a radical mechanism 
for the first time. To further elucidate the mechanism, different strategic substrate 
analogs were designed to trap the organic radical species, cobalamin intermediates and 
probe the radical substitution step. Based on all the isotope labeling studies and substrate 
analogs experiments, we were able to build a detailed mechanistic model to reveal how 
CysS uses cobalamin, SAM, [4Fe− 4S] cluster to perform the unusual iterative 
methylations. 
ChuW can catalyze a radical-mediated reaction to methylate and break the 
protoporphyrin ring of heme to release iron in an anaerobic heme degradation pathway. 




porphyrin ring by forming a porphyrin compound with cyclopropyl ring cleaved. Several 
tetrapyrrole ring and SAM adducts were also observed, which gives us further insight 
into the mechanism of the enzymatic porphyrin cleavage. 
ThiC is a non-canonical radical enzyme that catalyzes one of the most 
complicated rearrangements in all of the mechanistic enzymology, which is the 
conversion of the 5-aminoimidazole ribonucleotide (AIR) to form 4-amino-5-
hydroxymethyl-2-methylpyrimidine phosphate (HMP-P) in thiamin biosynthesis. Here, 
we were able to trap a four-carbon fragment from the ribose part of AIR by methionine 
during the enzymatic reaction. Using isotope labeling substrates and cofactors, we were 
able to show the intermediate leaks out after the first hydrogen atom abstraction but 
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1. INTRODUCTION  
 
1.1. Radical S-Adenosylmethionine (SAM) Enzymes 
Radical SAM enzymes, first classified as a superfamily in 2001,1 utilize a 
[4Fe−4S] cluster and SAM to initiate a diverse set of radical reactions that are otherwise 
difficult or impossible to catalyze by polar mechanisms. Radical SAM enzymes usually 
involve H-atom abstraction from an inactivated C−H bond via generation of a 5′-
deoxyadenosyl radical (5′-dA•) intermediate by reductive [4Fe−4S] cluster (Figure 1.1). 
Compared with iron(IV)-oxo-derived radicals, radical generated by hydrogen abstraction 
from 5′-dA is more persistent because iron-bound oxygen species is not available.2 Since 
the high intrinsic reactivity of organic radicals, radical SAM enzymes can catalyze a 










































For example, many radical SAM enzymes are involved in complicated cofactor 
biosynthesis (Figure 1.2). The thiamin pyrimidine synthase (ThiC) catalyzes a complex 
rearrangement of aminoimidazole ribotide (AIR) to form hydroxymethylpyrimidine 
phosphate (HMP-P) in thiamin biosynthesis.4 Hydroxybenzimidazole synthase (BzaF) 
carries out a similar rearrangement of AIR to form 5- hydroxybenzimidazole (HBI) in 
cobalamin biosynthesis.5 Aminofutalosine synthase (MqnE) catalyzes the addition of the 
adenosyl radical to the double bond of 3-[(1-carboxyvinyl)oxy]benzoic acid to form 
aminofutalosine in the menaquinone biosynthesis.6-7 F0-synthase (CofG/CofH or FbiC) 
cleaves tyrosine and couples it to pyrimidinedione to give the deazaflavin chromophore 
in coenzyme F420 biosynthesis.8 MoaA and MoaC catalyze the rearrangement of GTP 
into a cyclic pyranopterin monophosphate (cPMP) in molybdopterin biosynthesis.9-10 
 





Figure 1.2 Complex radical reactions catalyzed by radical SAM enzymes. (A) ThiC in 
thiamin biosynthesis (B) BzaF in cobalamin biosynthesis (C) MqnE in menaquinone 

































































































































The radical SAM superfamily has grown rapidly since 2001 and now contains 
almost 113,000 unique sequences that represent more than 65 distinct reactions.11 
Around 50,000 of the sequences relate to proteins have unknown function. Based on the 
radical SAM enzyme’s capability of catalyzing unusual reactions, it’s considered as a 
new treasure for the discovery of novel enzymatic transformations and biochemical 
pathways. 
1.1.1. Non-canonical radical SAM enzymes 
For most of the racial SAM enzymes that have been identified, their sequences 
contain a consensus CX3CX2C motif where each of the three cysteines coordinates with 
one of the three irons in [4Fe–4S] cluster. The fourth iron coordinates with the amino 
and carboxylate groups of SAM in a bidentate fashion. However, there are several 
enzymes that do not contain CX3CX2C motif but still generate a 5′-deoxyadenosyl 
radical to catalyze the reactions, such as ThiC (CX2CX4C), PhnJ (CX2CX21CX5C), QueE 
(CX14CX2C).4, 12-13 
Besides the difference of the conserved sequence for binding the [4Fe–4S] 
cluster, ThiC also lacks the classic SAM binding motifs.14 From the ThiC crystal 
structure with SAH or 5′-dA and L-methionine, it is suggested that in ThiC active site, 
SAM anchors to an additional active site metal through its amino and carboxylate groups 
instead of the iron in [4Fe–4S] cluster.15 It’s still not clear whether the captured 
conformation is in the catalytic cycle and whether this extra iron helps ThiC to catalyze 
such complicated rearrangement. What’s more, the [4Fe–4S] cluster-binding loop of 




radical enzymes. This swapped structure is most resembled the adenosylcobalamin 
(AdoCbl)-dependent enzymes (like glutamate mutase), which indicates an evolutionary 
relationship between the two super-families. 
Dph2 is another non-canonical radical SAM enzyme that uses reduced [4Fe-4S] 
cluster and SAM, but generates a 3-amino-3-carboxypropyl radical instead of a 5′-
deoxyadenosyl radical in the diphthamide biosynthesis. It is shown that Dph2 adopts a 
completely unrelated tertiary structure for [4Fe-4S] cluster binding and C𝛾,Met of SAM is 
closer to the unique Fe than the SMet in the classical radical SAM enzymes.16 This 
structure orientation helps to explain why SAM is reductively cleaved to form 3-amino-
3-carboxypropyl radical instead of a 5′-deoxyadenosyl radical.  
1.1.2. Radical SAM methyltransferases 
Before radical SAM enzyme has been classified as a superfamily, SAM was best 
known as a natural methyl donor in many important biological processes, including 
regulation of gene expression, protein modification, RNA processing.17 In classical 
methyltransferase (MTase) reactions, substrates need strong nucleophiles such as 
oxygen, nitrogen or sulfur to attack the methyl group of SAM, which is electrophilic due 
to the adjacent sulfonium of SAM.18 However, this nucleophilic SN2 methylation 
mechanism cannot apply to the saturated carbon atoms or electrophilic substrates. 
Alternatively, nature uses radical mechanisms to catalyze these unusual reactions.  
To date, all the known enzymes that catalyze radical-mediated methylation 
belong to the radical SAM superfamily. Sequence analysis reveals that the currently 




(Figure 1.3).19-20 Class A RSMTs have a single conserved radical SAM domain and use 
two conserved cysteine residues to methylate sp2-hybridized carbon atoms. Class B 
RSMTs include a cobalamin binding domain (CBD) at the N-terminal as well as a 
radical SAM domain at the C-terminus. Class C RSMTs has high sequence similarity 
with HemN at the C-terminus in addition to the classic TIM barrel radical SAM domain. 
Currently, RlmN and Cfr in the class A RSMTs are the most well-studied 
methyltransferases in radical SAM family.20  There are more and more reconstitutions 
and mechanistic studies for Class B RSMTs while there are few reconstituted examples 
for Class C RSMTs. 
 
 
Figure 1.3 Domain structures of different classes of RSMTs. 
 
As the data shown in 2017, the number of total radical SAM sequences are nearly 
















bioinformatics.21-22 Currently, class B RSMTs represents the largest class of RSMTs, 
which can catalyze a wide range of reaction including phosphinates, unactivated sp3-
hybridized carbons, and sp2-hybridized carbons. Van der Donk lab first proposed that 
methylation can be performed from methylcobalamin (MeCbl) to the substrate radical 
for these B12 dependent methyltransferases more than ten years ago.23 However, the poor 
solubility upon overexpression and the substrate complexity have hampered the 
reconstitution and detailed in vitro studies of these enzymes for a long time. Recently, 
Booker’s lab is able to develop a strategy to enhances the uptake of cobalamin into the 
cytoplasm and improves the solubility of the target enzymes significantly by co-
overexpression of Cbl uptake protein.24  Some of the earlier pioneer work in this area 
includes PhpK for the phosphinic acid P-methylation,25 GenK and Fom3 for the alcohol 
C-methylation,26-29 ThnK for the iterative C-methylation to form the ethyl group,30 TsrM 
for the aromatic C-methylation,31-32 PoyC for the valine residue C-methylation,33-34  






Figure 1.4 Selected secondary metabolites whose biosynthesis include class B RSMTs 
that have been reconstituted in vitro. Carbon atoms that are introduced by class B 
RSMTs are highlighted by red. 
 
Class C RSMTs share high sequence similarity with HemN at the C-terminus in 
addition to the classical TIM barrel radical SAM domain. Class C RS can methylate sp2-
hybridized carbon centers, but do not have the two conserved cysteines like RlmN, Cfr 
in the sequence. In the crystal structure of HemN, there are two simultaneously bound 
SAM molecules in the active site.36 Since, many residues in Class C RSMTs are 
conserved in HemN, including the residues for SAM binding, it has proposed that Class 
C RSMTs uses one molecular of SAM to generate 5′-dA radical and another molecule to 
provide methyl group. This suggests a possible mechanism in which the 5′dA• generated 
by the first SAM abstracts a hydrogen atom from the methyl group of the second SAM, 
which then can attack the unsaturated carbon to initiate the methylation.20 Qi’s group 






















methylthioadenosine (MTA) and then was used as a direct methyl donor after it was 
abstracted a hydrogen atom by 5′-dA radical, which is different than what Booker’s 
group observed.37-38  Due to the poor accessibility of the complicated substrates and a 
lack of knowledge of the step along the biosynthetic pathway, there are few systems 
reconstituted for the Class C RSMTs. Recent studies also revealed that Class C RSMTs 
can not only methylate sp2-hybridized carbon but also form cyclopropane rings or ester 
linkage (Figure 1.5). These include enzymes that catalyze the formation of cyclopropane 
rings formation (Jaw5 in jawsamycin biosynthesis, YtkT in yatakemycin biosynthesis, 
C10P and C10Q in CC-1065 biosynthesis),39-41 methylation of sp2-hybridized carbon 
(TbtI in thiomuracin biosynthesis, MenK/MqnK in menaquinone biosynthesis),42-43 
methylation and ester linkage (NosN in nosiheptide biosynthesis).38  
 
 
Figure 1.5 Class C radical SAM methyltransferases catalyzed modification (highlight in 

























2. RECONSTITUTION OF B12-DEPENDENT RADICAL SAM 
METHYLTRANSFERASE CysS CATALYZED t-BUTYLATION BY ITERATIVE 
METHYLATION*1 
2.1. Introduction 
Natural products with branched alkoxy groups play an important role in the 
development of bioactive compounds. In addition, the t-butyl group has fascinated 
organic chemists for more than a century and has played a major role in mechanistic 
studies on carbocation chemistry, organic substitution reactions, and the design and 
characterization of theoretically interesting molecules such as the remarkable tetra t-
butyl tetrahedrane.44 Although numerous t-butyl group substituted terpenes, polyketides 
and peptides have been identified, experimental studies on the biosynthesis of t-butyl 
groups are still at an early stage and many of the mechanistic proposals in the literature 
have not been adequately experimentally tested.45 
For the ginkgolides and several other t-butyl substituted terpenes, the t-butyl 
group is formed by a double bond methylation using S-adenosylmethionine (Figure 
2.1A).46  Formation of the t-butyl group in the coumarin swietenone is proposed to 
involve carbocation insertion into a CH bond to give a cyclopropyl intermediate, which 
                                                
* Reprinted in parts with permission from “Biosynthesis of Branched Alkoxy Groups: Iterative 
Methyl Group Alkylation by a Cobalamin-Dependent Radical SAM Enzyme” by Wang, Y.; 
Schnell, B.; Baumann, S.; Müller, R.; Begley, T. P.  2017, J. Am. Chem. Soc. 139,1742-1745. 
Copyright 2017 American Chemical Society. Reprinted from Methods Enzymol, 606, Wang, Y.; 
Schnell, B.; Muller, R.; Begley, T. P., Iterative Methylations Resulting in the Biosynthesis of the 
t-Butyl Group Catalyzed by a B12-Dependent Radical SAM Enzyme in Cystobactamid 





then undergoes acid mediated ring-opening (Figure 2.1B).47 The biosynthesis of pivalic 
acid, a starter unit in the biosynthesis of t-butyl substituted polyketides, is mediated by a 
vitamin B12-dependent mutase (Figure 2.1C).48-49 Recently, a B12/radical SAM mediated 
conversion of isopropyl glycine to t-butyl glycine in the polytheoamide propeptide was 
reported (Figure 2.1D).33-34 A polyketide synthase is also found to catalyze coupled 
decarboxylation and methylation reactions to form pivaloyl-ACP from dimethylmalonyl-
ACP in the apratoxin A biosynthesis(Figure 2.1E).50 However, all of these enzymes 
catalyze a single methyl transfer to form the t-butyl group from an isopropyl group.  
 
 





















































































The cystobactamids are a novel class of isopropyl substituted antibacterial 
compounds produced by myxobacteria.51 The biosynthetic gene cluster has been 
identified and sequence analysis suggested that CysS is a cobalamin-dependent radical 
SAM methyltransferase, potentially involved in the iterative methylations of the 3-
methoxy-4-aminobenzoic acid moieties of cystobactamid 2-19 (Figure 2.2). Some minor 
derivatives exhibit methyl, ethyl, isopropyl, and sec-butyl groups (Stephan Hüttel and 
R.M., unpublished results) supporting the hypothesis of CysS being an enzyme 
iteratively adding methyl-groups to its substrate. 
 
 
Figure 2.2 Proposed formation of branched alkoxy groups of cystobactamids by CysS-
catalyzed iterative methylations of a methyl ether. 
 
Here we successfully reconstitute CysS in vitro and demonstrate that this enzyme 
can assemble isopropyl, sec-butyl, and t-butyl groups by sequential methylations of a 
methyl group. To our knowledge, this is the first example of an isopropyl, sec-butyl, and 













R1 = Et, i-Pro, 2-butyl





















2.2. Result and discussion 
2.2.1. Reconstitution of CysS activity with minimal substrates 
CysS was cloned into a pET28b vector and co-expressed with a plasmid 
encoding the suf operon ([4Fe-4S] biosynthesis)52 in Escherichia coli BL21 (λDE3). The 
protein was then purified, under anaerobic conditions, by Ni-NTA affinity 
chromatography. The UV−visible spectrum of purified CysS revealed a 420 nm 
shoulder, typical of a bound Fe/S cluster (Figure 2.3). Iron and sulfide analysis yielded 
2.5 irons and 2.8 sulfides per monomer of CysS, demonstrating partial cluster formation 
in the overexpressed protein. 
 
 
Figure 2.3 (A) UV spectrum of purified CysS (B) SDS/PAGE analysis of purified CysS. 
 
Several p-aminobenzoic acid (PABA) analogs were tested as substrates for CysS. 
None gave the desired methylated product as indicated by LC-MS analysis. Further 

























carrier protein thioester of 2-17 (CysG)51 as possible CysS substrates. To test this 
proposal, N-acetylcysteamine thioester 2-20 was synthesized and incubated with CysS, 
SAM, MeCbl, and flavodoxin/flavodoxin reductase/NADPH (Figure 2.4). LC-MS 
analysis of the resulting reaction mixture demonstrated the formation of the ethyl ether 
2-21(Figure 2.5A). This was further confirmed by co-elution of the reaction product with 
a synthesized sample of 2-21 (Figure 2.5D). When the ethyl ether 2-21 was incubated 
with CysS, the isopropyl ether 2-22 was detected by LC-MS analysis (Figure 2.5C). 
 
 
Figure 2.4 Identification of two substrates for CysS. A competition reaction with a 1:1 




















































a: R = Et
b: R = i-Pro
c: R = t-Bu










Figure 2.5 LC-MS detection of the CysS reaction products using methyl ether 2-21 and 
ethyl ether 2-22. Red trace is the full reaction where all the components are present. 
Orange, cyan, blue, black and green traces respectively are for reaction mixtures where 
either CysS, MeCbl, SAM, substrate, or reducing system flavodoxin/flavodoxin 
reductase/NADPH) is absent. (A) EIC of compound 2-21 [M+H]+ (283.11±0.02) (B) 
EIC of 5¢-dA [M+H]+ (252.10±0.02) (C) EIC of compound 2-22  [M+H]+ (297.13±0.02) 
(D) EIC of compound 2-22  co-elution with an authentic sample [M+H]+ (283.11±0.02). 
Red trace is the full enzymatic reaction. Purple trace is compound standard 2-22. Green 
trace is the co-elution of the enzymatic product and the synthetic standard. 
 








Full WAM87NAC_1-E,2_01_20438.d: EIC 283.1111±0.02 +All MS no CysS_1-E,3_01_20439.d: EIC 283.1111±0.02 +All MS no Fld_1-E,7_01_20444.d: EIC 283.1111±0.02 +All MS
no MeCbl_1-E,6_01_20443.d: EIC 283.1111±0.02 +All MS no SAM_1-E,5_01_20441.d: EIC 283.1111±0.02 +All MS no WAM87NAC_1-E,4_01_20440.d: EIC 283.1111±0.02 +All MS







Full WAM87NAC_1-E,2_01_20438.d: EIC 252.1091±0.02 +All MS no CysS_1-E,3_01_20439.d: EIC 252.1091±0.02 +All MS no Fld_1-E,7_01_20444.d: EIC 252.1091±0.02 +All MS
no MeCbl_1-E,6_01_20443.d: EIC 252.1091±0.02 +All MS no SAM_1-E,5_01_20441.d: EIC 252.1091±0.02 +All MS no WAM87NAC_1-E,4_01_20440.d: EIC 252.1091±0.02 +All MS









Full WAM87NACethyl_1-E,1_01_20664.d: EIC 297.1267±0.02 +All MS No CysS WAM87NACethyl_1-E,2_01_20665.d: EIC 297.1267±0.02 +All MS
no Fld WAM87NACethyl_1-E,6_01_20669.d: EIC 297.1267±0.02 +All MS no MeCbl WAM87NACethyl_1-E,5_01_20668.d: EIC 297.1267±0.02 +All MS



























































Pantetheinyl thioester 2-23 was a better substrate for CysS and iterative 
methylations to give the ethyl, isopropyl, and the butyl ethers were detected by LC-MS 
analysis (Figure 2.6). Small amounts of the ethers 2-24a and 2-24b were detected in the 
absence of the reducing agent suggesting that some of the purified enzyme contained the 
reduced [4Fe−4S] cluster. To confirm the structures of 2-24a-c, authentic samples of 
these compounds were synthesized. The enzymatic products matched the synthetic 
standards in terms of retention time, exact mass, and fragmentation pattern (Figure 2.12, 
2.13). In addition, CysS catalyzed the conversion of synthetic 2-24a to 2-24b-d and the 
conversion of synthetic 2-24b to 2-24c, d (Figure 2.15). The second component in the 
extracted ion chromatogram for the t-butyl ether 2-24c (Figure 2.6C, D) was identified 






Figure 2.6 LC-MS analysis of CysS-catalyzed iterative methylations of methyl ether 2-
23. Red trace is for the complete reaction mixture. Green trace is for reaction mixtures 
where the reducing system (flavodoxin/ flavodoxin reductase/NADPH) is absent. Ethyl 
ether 2-24a, isopropyl ether 2-24b were not formed in the control reactions lacking 
CysS, SAM, or MeCbl. (A) Extracted ion chromatograms (EICs) of the ethyl ether 2-24a 
[M + H]+ (442.20 ± 0.02). (B) EICs of the isopropyl ether 2-24b [M + H]+ (456.22 ± 
0.02). (C) EICs of the t-butyl ether 2-24c [M + H]+ (470.23 ± 0.02). (D) EICs of [M + 
H]+ (470.23 ± 0.02) showing co-migration with a synthesized sample of 2-24c. Cyan 
trace is the t-butyl ether standard. Blue trace is co-elution of the enzymatic product and 
synthetic standard. The second component in the extracted ion chromatogram for the t-
butyl ether 2-24c (panels C, D) was identified as the sec-butyl ether 2-24d.  






No Fld pant_1-F,2_01_20899.d: EIC 470.2319±0.001 +All MS, Smoothed (2.17,1,GA) No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.002 +All MS
No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.005 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 470.2319±0.002 +All MS, Smoothed (2.27,1,GA)
Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.002 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.005 +All MS









No Fld pant_1-F,2_01_20899.d: EIC 456.2163±0.2 +All MS No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.002 +All MS
No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.005 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 456.2163±0.2 +All MS
Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.002 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.005 +All MS








No Fld pant_1-F,2_01_20899.d: EIC 442.2006±0.02 +All MS No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.002 +All MS
No Fld pant_1-F,2_01_20899.d: EIC 10000.0000±0.005 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 442.2006±0.02 +All MS
Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.002 +All MS Full WAM87pant_1-E,7_01_20895.d: EIC 10000.0000±0.005 +All MS
Retention	 time	
(minutes)
























































Various [4Fe−4S] cluster reducing agents were tested in addition to the 
flavodoxin/flavodoxin reductase/NADPH. NADPH/methyl viologen, a commonly used 
electron source for cobalamin-dependent radical SAM enzymes, gave similar activity. 
However, dithionite or the combination of methyl viologen and dithionite gave a 
significantly lower activity.53 Buffer thiols inactivate the substrate by trans 
thioesterification and need to be avoided. 
Quantitative analysis of the enzymatic reaction mixture (CysS, methyl ether 2-
23, flavodoxin/flavodoxin reductase/NADPH, reaction run to completion) by LC-MS 
showed that 1 equiv of enzyme undergoes >2 turnovers, generating around 2.0 equiv of 
5′-dA, 2.0 equiv of SAH, 1.4 equiv of ethyl ether 2-24a and 0.3 equiv of isopropyl ether 
2-24b (Figures 2.6 and 2.7). The t-butyl ether 2-24c was detected only when the 
concentration of the isopropyl ether 2-24b was >23 µM. The ratio of 5′-dA to SAH was 
close to 1, suggesting that two molecules SAM were consumed for each methylation 
reaction and that the uncoupled production of 5′-dA is low. This is consistent with SAM 
functioning as the source of both the adenosyl radical and the methyl group and was 
further supported by LC-MS analysis of a reaction mixture containing CD3-SAM which 






Figure 2.7 LC-MS detection of 5ʹ-dA and SAH in the CysS-catalyzed iterative 
methylations of the methyl ether 2-23. Red trace is for the complete reaction mixture. 
Green trace is for reaction mixtures where the reducing system (flavodoxin/flavodoxin 
reductase/NADPH) is absent. (A) EICs of 5ʹ-dA [M + H]+ (252.11 ± 0.02). (B) EICs of 
SAH [M + H]+ (385.13 ± 0.02). Yellow, green, cyan, and black traces are for reaction 
mixtures where either CysS, reducing system, MeCbl or substrate is absent. The product 











Full WAM87pant_1-E,7_01_20895.d: EIC 385.1289±0.02 +All MS No CysS pant_1-E,8_01_20896.d: EIC 385.1289±0.02 +All MS
No Fld pant_1-F,2_01_20899.d: EIC 385.1289±0.02 +All MS No MeCbl pant_1-F,1_01_20898.d: EIC 385.1289±0.02 +All MS
No SAM pant_1-E,9_01_20897.d: EIC 385.1289±0.02 +All MS No substrate _1-E,3_01_20891.d: EIC 385.1289±0.02 +All MS







Full WAM87pant_1-E,7_01_20895.d: EIC 252.1091±0.02 +All MS No CysS pant_1-E,8_01_20896.d: EIC 252.1091±0.02 +All MS
No Fld pant_1-F,2_01_20899.d: EIC 252.1091±0.02 +All MS No MeCbl pant_1-F,1_01_20898.d: EIC 252.1091±0.02 +All MS

























Figure 2.8 MS analysis of a reaction mixture in which CH3-SAM is replaced with CD3-
SAM showing CD3 incorporation into the ethyl and isopropyl ethers of 2-24a and 2-24b, 
respectively. Panels A and C: Mass spectra of 2-24a and 2-24b formed from CH3-SAM. 
Panels B and D: Mass spectra of 22a and 22b formed from CD3-SAM.  
 
A mechanistic proposal for the CysS-catalyzed reaction, based on the proposed 
mechanisms for GenK and ThnK is shown in Figure 2.9. After initial formation of 
methylcobalamin by SAM mediated methylation, reductive cleavage of SAM by the 
[4Fe− 4S] +1 cluster generates the 5′-deoxyadenosyl radical. This abstracts a hydrogen 
atom from the methyl group of the substrate 2-23 to give radical 2-25, which then 
undergoes a radical substitution with methyl cobalamin to give the ethyl ether 2-24a. An 
analogous methyl transfer, by a radical substitution mechanism, has precedence in 
cobalamin model chemistry.54 Regeneration of MeCbl from Cbl(II) can be achieved by 
reduction to Cbl(I) by the [4Fe−4S]+1 cluster followed by SAM-mediated methylation. 
Repetition of this sequence results in the successive formation of the isopropyl, t-butyl, 





Figure 2.9 Proposal for CysS-catalyzed iterative methylations to form branched alkoxy 
groups. The mechanism assumes two different SAM binding sites. It is also possible that 
SAM binds to a single site and that the position of the sulfonium moiety is altered by a 
protein conformational change.  
 
2.2.2. Reconstitution of CysS activity with native substrates 
The most logical substrate for CysS is the 4-amino-3-methoxybenzoate thioester 
with the peptidyl carrier protein of the polypeptide synthase.51 This was synthesized as 
shown in Figure 2.10. Condensation of 2-26 with coenzyme A yielded the CoA ester 2-
27. The phosphopantetheinyl thioester moiety of 2-27 was then transferred to CysG1 in a 













































































































































Figure 2.10 Synthesis of the 4-amino-3-methoxybenzoate (AMB) CysG1 thioester 2-28. 
Adapted with permission from 55. 
 
When AMB-CysG1 thioester was incubated with CysS, MeCbl, SAM and 
methyl viologen, dimethylated 2-29a and trimethylated products 2-29b were detected by 
LC-MS (the formation of trimethylated products required higher enzyme concentrations) 
(Figure 2.11). This further demonstrated that the peptide carrier protein thioester of 2-28 





Figure 2.11 The CysS-catalyzed reaction of the AMB-CysG1 thioester. (A) MS of the 
dimethylated product (APB-CysG1 thioester 2-29a, calculated monoisotopic mass: 
73217.8Da, experimental mass: 73218.0Da), (B) MS of the trimethylated product (ABB-
CysG1 thioester 2-29b, calculated monoisotopic mass: 73231.7Da, experimental mass: 
73232.7Da), (C) The reaction catalyzed by CysS. Adapted with permission from 55. 
 
2.3. Conclusion 
Here we describe the successful in vitro reconstitution of CysS and demonstrate 
that this enzyme can assemble isopropyl, sec-butyl, and t-butyl groups by sequential 
methylations of a methyl group. To our knowledge, this is the first example of an 
isopropyl, sec-butyl, and a t-butyl group biosynthesis from a methyl group using radical 




biosynthesize a combinatorial antibiotic library of 25 cystobactamid analogs. Analogous 
methyl-based combinatorial libraries could potentially be generated in natural products 
such as kedarcidin and quinomycin SW-163s, which have ethyl, isopropyl, and sec-butyl 
substituents on a thiomethyl group.56-57 
2.4. Experimental methods 
2.4.1. overexpression and purification of CysS 
A 15mL overnight culture was grown in LB medium in the presence of 40 µg/mL 
kanamycin and 30 µg/mL chloramphenicol. This was then added to 1.5 L of LB medium 
containing 40 µg/mL kanamycin and 30 µg/mL chloramphenicol. The cultures were 
incubated at 37°C with shaking (180 rpm) until the OD600 reached 0.45. The culture 
was then incubated at 4°C without shaking for 1 hour. Expression was induced by the 
addition of 100 µM IPTG followed by ferrous ammonium sulfate (120 mg) and cysteine 
(120 mg) and the culture was grown at 15 °C with shaking (110 rpm) overnight. The 
cells were harvested by centrifugation and stored in liquid nitrogen until further use. All 
steps for protein purification were carried out in an anaerobic chamber (COY 
laboratories). Cell pellets (~12 g) were thawed and resuspended in 30 mL lysis buffer 
(100 mM Tris-HCl, pH 7.5) in the presence of lysozyme (0.2 mg/mL) and benzonase 
(100 units). This mixture was cooled in an ice-bath with continuous stirring for 1-2 hrs. 
The suspension was then sonicated to complete cell lysis for 5 × 120 s using a Misonix 
Sonicator XL-2000 (setting = 9). Cell debris was removed by centrifugation, and the 
lysate was loaded onto a Histrap column pre-equilibrated with lysis buffer. The column 




Imidazole, pH 7.5). The CysS protein was then eluted using elution buffer (100 mM 
Tris-HCl, 300 mM NaCl, 250 mM imidazole, pH 7.5). The brown-colored fractions, 
containing the desired protein, were pooled and buffer exchanged to final buffer (100 
mM Tris-HCl, pH 7.5 at 25 °C, 30% glycerol) using Econo-Pac 10DG size exclusion 
chromatography. The purified CysS was divided into aliquots in eppendorf tubes, frozen 
in liquid nitrogen, and stored at −80 °C, submerged in liquid nitrogen, until future use. 
Each tube has a pin hole in the cap to allow for gas release during thawing. Protein 
concentration was measured by the absorbance at 280 nm (A280) when the protein was 
exposed to air or the [4Fe-4S]2+ cluster was reduced to [4Fe-4S]1+ by dithionite 
(prevent the interference from absorbance from [4Fe-4S]2+) with an extinction 
coefficient calculated using the ProtParam tool of the ExPASy proteomics server. 
Typical yields were approx. 5 mg per liter. 
2.4.2. Iron and sulfide quantification of CysS 
Iron content was analyzed using the ferene assay (Cooper et al., 2013). The 
following reagents were prepared: A, 1.35 g SDS, 30 mL water, 450 µL saturated 
sodium acetate; B, 540 mg L-ascorbic acid, 18 mg sodium metabisulfite, 11.2 mL water, 
800 µL saturated sodium acetate; C, 18 mg ferene in 1 mL water. Guanidine 
hydrochloride (8M, 300 µL), Reagent A (300 µL), and Reagent B (300 µL) were added 
to 300 µL of a CysS solution. After mixing by inversion, the samples were incubated for 
15 min at 37 °C and then 15 µL of Reagent C was added. The samples were incubated 
for 5 min at 25 °C and centrifuged for 5 min at 25 °C. The absorbance at 593 nm of the 




The iron content was finally determined by comparing the reading to a standard curve 
that was generated under identical conditions using FeCl3 in 2% HNO3 with a 
concentration range from 0 to 200 µM. 
Sulfide content was determined using the methylene blue assay.6 To 300 µL of 
the assay solution containing CysS, 1 ml of 1% (w/v) zinc acetate was added followed 
by 50 µL of 3 M NaOH. This mixture was agitated gently and 250 µL of 0.1 % N, N-
dimethyl-p-phenylenediamine (DMPD) monohydrochloride in 5 M HCl and 50 µL of 23 
mM FeCl3 in 1.2 M HCl were added. The resulting solution was mixed vigorously for 
30 mins. The samples were then centrifuged for 10 min at 25 °C. The supernatant was 
collected and the absorbance at 670 nm was recorded using a Varian Cary Bio 300 UV-
Visible Spectrophotometer. The sulfide content was determined by comparing this 
reading to a standard curve that was generated under identical conditions using a fresh 
solution of sodium sulfide (Na2S) in 0.1 M NaOH with a concentration range from 0 to 
100 µM. 
2.4.3. In vitro reconstitution assay with CysS: 
All CysS enzymatic reactions were carried out in an anaerobic chamber 
containing 95% nitrogen and 5% hydrogen. A typical enzymatic reaction was performed 
in 100 mM phosphate buffer, pH 7.5 containing 55 µM of CysS with 0.75 mM MeCbl, 
2.5 mM SAM, 0.9 mM substrate with different reducing systems, flavodoxin, flavodoxin 
reductase system (25 µM FldA, FPR; 50 µM FAD, FMN; 3 mM NADPH); 1 mM 
methyl viologen, 4 mM NADPH; 10 mM dithionite, 10 mM dithiothreitol (DTT); 1 mM 




50 mM DTT. The reaction was incubated at room temperature for 12-15 hours. For LC-





Figure 2.12 LC-MS detection of 2-24a in the CysS reaction using methyl ether 2-23 as 
substrate. Red trace is the enzymatic full reaction. Green trace is the co-elution of the 
enzymatic product and synthetic standard of the ethyl ether 2-24a (A) EIC of ethyl ether 
2-24a [M+H]+ (442.20±0.02). (B) Mass spectrum of ethyl ether 2-24a (exact mass: 
442.2021, Accuracy: <1 ppm). (C) Mass fragments of the ethyl ether 2-24a produced in 
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Figure 2.13 LC-MS detection of 2-24b in the CysS reaction using methyl ether 2-23 as 
substrate. Red trace is enzymatic full reaction. Blue trace is synthetic standard of 
isopropyl ether 2-24b (A) EIC of isopropyl ether 2-24b [M+H]+ (456.21±0.02). (B) 
Mass spectrum of isopropyl ether 2-24b (exact mass: 456.2171, Accuracy: 1.7 ppm). (C) 
Mass fragments of the isopropyl ether 2-24b produced in the enzymatic reaction. (D) 
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Figure 2.14 LC-MS detection of 2-24c in the CysS reaction using methyl ether 2-23 as 
substrate. (A) Mass spectrum of t-butyl ether 2-24c (exact mass: 470.2322, Accuracy: 
3.4 ppm). (B) Mass fragments of t-butyl ether 2-24c produced in the enzymatic reaction. 
(C) Mass fragments of synthetic standard of t-butyl ether 2-24c.  
 
 
Figure 2.15 LC-MS detection of the CysS reaction products using ethyl ether 2-24a (A), 
(B) or isopropyl ether 2-24b (C). (A) EIC of isopropyl ether 2-24b [M+H]+ 
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Figure 2.15 Continued 
 
 
Figure 2.16 LC-MS detection of the CysS reaction products using isopropyl ether 2-24b 
as substrate. The second peak was co-migrated with an authentic standard of sec-butyl 
ether 2-24d. Red trace is EIC of mass (470.23±0.02) for enzymatic full reaction. Green 
trace is synthetic standard of sec-butyl ether 2-24d. 
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Figure 2.17 LC-MS detection of 5¢-dA produced in the CysS reaction products using (A) 
methyl ether 2-23 or (B) CD3-methyl ether CD3-2-23 as substrate. 
 
2.4.4. LC-MS parameters for the analysis of the CysS reaction mixture 
LC-ESI-TOF-MS was performed using an Agilent 1260 HPLC system equipped 
with a binary pump and a 1200 series diode array detector followed by a MicroToF-Q II 
mass spectrometer (Bruker Daltonics) using an ESI source in positive mode. Analysis 
was performed on a LC-18-T column (15 cm x 3 mm, 3 µm particles, Supelco). 
LC conditions: 
A- 5 mM Ammonium acetate buffer, pH 6.6  
B- 75 % Methanol and 25 % Water. 
LC method:  
0min – 100% A, 2 min – 100% A, 4 min – 80% A 20% B, 27 min – 100% B, 29 






























The mass spectrometer parameters for small molecules: Capillary, 4500 V; end 
plate offset, 500 V; nebulizer gas, 3.0 bar; dry gas, 10.0 L/min; dry gas temperature, 
200°C; funnel 1 RF, 250.0 Vpp; funnel 2 RF, 300.0 Vpp; isCID, 0.0 eV; hexapole RF, 
200 Vpp; quadrupole, Ion energy, 3.0 eV; low mass, 150 m/z; collision cell, collision 
energy, 8.0 eV; collision RF, 150.0 Vpp; transfer time, 80.0 µs; prepulse storage, 5.0 µs. 
Data were processed with DataAnalysis ver. 4.0 (Bruker Daltonics). 
2.4.5. Quantification of enzymatic products in the CysS reaction mixture 
The CysS assay, using methyl ether 2-23 was carried out under the above 
conditions with flavodoxin, flavodoxin reductase or methyl viologen, NADPH as 
reducing systems. Calibration curves were constructed by measuring the peak intensity 
of 5′-dA, SAH, synthetic ether 2-21, 2-24a and 2-24b with known concentration using 
LC-MS. Then the calibration curves were used to measure the concentration of 5′-dA, 
SAH, 2-21, 2-24a and 2-24b in the enzymatic reaction. Control reactions without CysS 
were used to assess the quantity of non-enzymatically produced SAH and this amount 
was subtracted out of the enzymatic reaction to give the final result. With our current 
enzyme preparation, 55 µM of CysS with 0.75 mM MeCbl, 2.5 mM SAM, 0.9 mM 
substrate and flavodoxin, flavodoxin reductase system (25 µM FldA, FPR; 50 µM FAD, 
FMN; 3 mM NADPH) produced 111 µM of 5′-dA, 109 µM of SAH, 78 µM of ethyl 
ether 2-24a, 15 µM of isopropyl ether 2-24b. The relative rate of 2-20 and 2-23 was 
measured by the amount of product formations of 2-21 and 2-24 by CysS with 1:1 ratio 




mM 18, 0.5 mM 21, and 1 mM methyl viologen, 3 mM NADPH produced 0.4 uM of 2-
21, 15.8 µM of 2-24a, 3.2 µM of 2-24b. 
2.4.6. General procedure for the synthesis of the 4-nitrobenzoic acids (2-32a, b, d) 
 
Potassium hydroxide (5.0 mmol) was added to a solution of 3-fluoro-4-
nitrobenzoic acid (2.0 mmol) 31 in excess of alcohol (10 ml) and the reaction mixture 
was slowly heating to reflux for several hours and monitored by TLC (Hexane and 
EtOAc solvent system). Then it was acidified using 2N HCl and extracted with ethyl 
acetate. The extracts were combined, washed with water, dried with MgSO4 and 
evaporated to give 4-nitro-benzoic acids 2-32a, b and d.  
3-ethoxy-4-nitrobenzoic acid (2-32a) 
Compound 2-32a was prepared by the above procedure using ethanol in 63% 
yield. 1H NMR (400 MHz, MeOD) δ 7.80 (m, 2H), 7.68 (d, J = 9.8 Hz, 1H), 4.26 (q, J = 
7.0 Hz, 2H), 1.43 (t, J = 7.0 Hz, 3H). 13C NMR (101 MHz, MeOD) δ 152.59, 136.72, 
125.79, 122.58, 116.71, 106.43, 66.77, 14.72. 
3-isopropoxy-4-nitrobenzoic acid (2-32b) 
Compound 2-32b was prepared by the above procedure using isopropyl alcohol 
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(d, J = 8.3 Hz, 1H), 4.80 (m, 1H) 1.36 (d, J = 6.0 Hz, 6H). 13C NMR (101 MHz, MeOD) 
δ 172.96, 151.57, 136.51, 125.75, 122.57, 118.13, 74.13, 22.03, 20.85. 
3-(sec-butoxy)-4-nitrobenzoic acid (2-32d) 
Compound 2-32d was prepared by the above procedure using 2-butanol in 37% 
yield. 1H NMR (400 MHz, MeOD) δ 7.87 – 7.72 (m, 2H), 7.66 (d, J = 8.3 Hz, 1H), 4.68 
– 4.51 (m, 1H), 1.82 – 1.60 (m, 2H), 1.33 (d, J = 6.1 Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H). 
13C NMR (101 MHz, MeOD) δ 167.76, 151.82, 136.52, 125.75, 122.40, 117.79, 106.38, 
78.82, 30.03, 19.21, 9.67. 
3-(tert-butoxy)-4-nitrobenzoic acid (2-32c)  
  
3-fluoro-4-nitrobenzoic acid 2-31 (0.5 mmol) was dissolved in 5 ml anhydrous 
THF in a flame-dried flask under argon and cooled to 0 °C. A 1.0 M solution of 
potassium tert-butoxide (1.5 mmol) was added dropwise. This solution was stirred and 
allowed to warm from 0 °C to room temperature overnight and then diluted with ethyl 
acetate and washed with saturated aqueous NH4Cl. The aqueous layer was back-
extracted with CH2Cl2. The organic layers were combined, dried over MgSO4, and 
concentrated. Purification of the crude mixture by flash chromatography (silica gel, 15:1 











7.90 (s, 1H), 7.80 (d, J = 8.3 Hz, 1H), 7.74 (d, J = 8.3 Hz, 1H), 1.43 (s, 9H). 13C NMR 
(101 MHz, MeOD) δ 167.63, 149.76, 125.76, 125.37, 124.96, 84.11, 29.08. 
2.4.7. General Procedure for synthesis of 4-aminobenzoic acids (33a-d) 
  
Using 10% Pd/C as catalyst, 50 mL of 4-nitrobenzoic acid (2.0 mmol) in 
methanol was pumped through the H-Cube®. The pressure of the system was set to full 
hydrogen mode, and the temperature to 35 °C. The flow rate was 0.8 mL/min. The 
fraction was analyzed using TLC, which showed complete conversion to the product, 
and the solvent was reduced to dryness, affording the 4-aminobenzoic acids 2-33a-d. 
4-amino-3-ethoxybenzoic acid (2-33a) 
Compound 2-33a was prepared by the above procedure from 3-ethoxy-4-
nitrobenzoic acid 2-32a in 98% yield. 1H NMR (400 MHz, MeOD) δ 7.57 – 7.30 (m, 
2H), 6.71 (d, J = 8.2 Hz, 1H), 4.09 (q, J = 7.0 Hz, 2H), 1.43 (t, J = 7.0 Hz, 3H). 13C 
NMR (101 MHz, MeOD) δ 170.56, 146.83, 143.50, 125.45, 120.08, 114.36, 113.49, 
65.07, 15.11.  
4-amino-3-isopropoxybenzoic acid (2-33b) 
Compound 2-33b was prepared by the above procedure from 3-isopropoxy-4-
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2H), 6.70 (s, 1H), 4.58 (m, 1H), 1.34 (d, J = 6.0 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 
171.77, 145.15, 126.99, 115.39, 113.88, 112.36, 72.35, 26.60, 22.32. 
4-amino-3-(tert-butoxy) benzoic acid (2-33c) 
Compound 2-33c was prepared by the above procedure from 3-(tert-butoxy)-4-
nitrobenzoic acid 2-32c in 99% yield. 1H NMR (400 MHz, MeOD) δ 7.56 (s, 1H), 7.54 
(d, J = 8.3 Hz, 1H), 6.71 (d, J = 8.3 Hz, 1H), 1.39 (s, 9H).  13C NMR (101 MHz, MeOD) 
δ 170.48, 148.85, 142.48, 127.64, 125.04, 119.07, 114.84, 81.01, 29.10. 
4-amino-3-(sec-butoxy) benzoic acid (2-33d) 
Compound 2-33d was prepared by the above procedure from 3-(sec-butoxy)-4-
nitrobenzoic acid 2-32d in 97% yield. 1H NMR (400 MHz, MeOD) δ 7.51 – 7.35 (m, 
2H), 6.69 (d, J = 8.2 Hz, 1H), 4.36 (m, 1H), 1.86 – 1.57 (m, 2H), 1.30 (d, J = 6.1 Hz, 
3H), 1.00 (t, J = 7.5 Hz, 3H). 
S-(2-acetamidoethyl) 4-amino-3-methoxybenzothioate (2-20) 
  
To a solution of triethylamine (TEA) (2.80 mmol) in dichloromethane (10 mL) 
was added 4-amino-3-methoxybenzoic acid 2-34 (1.40 mmol), (3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) (1.40 mmol), 1-
hydroxybenzotriazole (HOBt) (1.40 mmol) and N-acetylcysteamine (SNAC) (1.4 
















washed with saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried 
over anhydrous sodium sulfate and concentrated under vacuum. Purification of the crude 
mixture by flash chromatography (silica gel, 1:1 to 2:1 of hexanes:EtOAc) afforded 2-20 
in 20% isolated yield. 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.2, 1H), 7.36 (s, 1H), 
6.63 (d, J = 8.2 Hz, 1H), 3.89 (s, 3H), 3.51 (dd, J = 12.2, 5.9 Hz, 2H), 3.18 (t, J = 6.3 Hz, 
2H), 1.95 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 190.29, 170.29, 146.21, 142.34, 
126.60, 122.85, 112.78, 108.72, 55.63, 40.08, 28.31, 23.21.  
S-(2-acetamidoethyl) 4-amino-3-ethoxybenzothioate (2-21) 
  
Compound 2-21 was prepared from 4-amino-3-methoxybenzoic acid 2-33a in the 
same manner as the above procedure in 30% yield. 1H NMR (400 MHz, CDCl3) δ 7.49 
(d, J = 8.2 Hz, 1H), 7.33 (s, 1H), 6.62 (d, J = 8.2 Hz, 1H), 4.09 (q, J = 7.0 Hz, 2H), 3.48 
(dd, J = 12.3, 5.9 Hz, 2H), 3.15 (t, J = 6.3 Hz, 2H), 1.93 (s, 3H), 1.42 (t, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 190.30, 170.29, 145.49, 142.45, 126.56, 122.69, 112.80, 



















2.4.8. General Procedure for synthesis of S-pantetheinyl-4-aminobenzothioate (2-
24a-d)  
 
To a stirred solution of 4-aminobenzoic acid 2-33 (2.0 mmol) in 10 mL of dry 
THF was added N-hydroxysuccinimide (NHS) (2.0 mmol), followed by N, N'-
Dicyclohexylcarbodiimide (DCC) (2.0 mmol) at room temperature. The resulting 
mixture was stirred overnight at room temperature. The white precipitate was filtered 
and then washed with EtOAc. The filtrate was concentrated under reduced pressure. The 
residue was triturated with CH2Cl2 to give the NHS ether of 2-33 as a pale brown 
powder. Pantethine (0.075 mmol), sodium bicarbonate (1.9 mmol), and 1,4-dithiothreitol 
(DTT) (0.08 mmol) were dissolved in 3 mL of water, and left to stand for 10 minutes to 
allow reduction of the pantethine to pantetheine to take place. The NHS ester (0.54 
mmol) was dissolved in 7 mL of tetrahydrofuran (THF) and added to the 3 mL water 
mixture. The reaction mixture was stirred overnight and then the solvent was evaporated 
under reduced pressure. The crude product was then dissolved in water and the insoluble 
residue was removed by filtration. The resulting solution was lyophilized and purified by 
flash chromatography (silica gel, 20:1 to 10:1 CH2Cl2: MeOH).  The fraction was further 
purified by Prep HPLC using a SPLC-18DB column (10 x 250 mm, 5 µm, Supelco) at a 
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Compound 2-33 was prepared by the above procedure from 4-amino-3-
methoxybenzoic acid 2-34. 1H NMR (400 MHz, D2O) δ 7.52 (dd, J = 8.3, 1.9 Hz, 1H), 
7.35 (d, J = 1.9 Hz, 1H), 6.79 (d, J = 8.3 Hz, 1H), 3.91 (s, 1H), 3.88 (s, 3H), 3.47 – 3.29 
(m, 6H), 3.17 (t, J = 6.3 Hz, 2H), 2.44 (t, J = 6.5 Hz, 2H), 0.83 (d, J = 13.9 Hz, 6H). 13C 
NMR (101 MHz, D2O) δ 193.17, 175.04, 174.02, 146.63, 126.36, 123.04, 114.04, 
109.43, 75.86, 68.49, 55.92, 38.93, 38.58, 35.50, 35.33, 28.03, 22.30, 20.46, 19.11. 
(R)-S-pantetheinyl-4-amino-3-ethoxybenzothioate (2-24a) 
Compound 2-24a was prepared by the above procedure from 4-amino-3-
ethoxybenzoic acid 2-33a. 1H NMR (400 MHz, D2O) δ 7.56 (dd, J = 8.3, 1.9 Hz, 1H), 
7.41 (d, J = 1.8 Hz, 1H), 6.84 (d, J = 8.3 Hz, 1H), 4.15 (q, J = 7.0 Hz, 2H), 3.91 (s, 1H), 
3.54 – 3.25 (m, 6H), 3.20 (t, J = 6.2 Hz, 2H), 2.44 (t, J = 6.5 Hz, 2H), 1.40 (t, J = 7.0 Hz, 
3H), 0.83 (d, J = 13.8 Hz, 6H). 13C NMR (101 MHz, D2O) δ 193.40, 175.05, 174.08, 
145.68, 143.76, 126.41, 123.11, 114.25, 111.11, 75.86, 68.48, 65.24, 38.90, 38.58, 
35.51, 35.34, 28.06, 20.45, 19.09, 14.02. 
(R)-S-pantetheinyl-4-amino-3-isopropoxybenzothioate (2-24b) 
Compound 2-24b was prepared by the above procedure from 4-amino-3-
isopropoxybenzoic acid 2-33b.  1H NMR (400 MHz, D2O) δ 7.54 (dd, J = 8.4, 1.8 Hz, 
1H), 7.45 (d, J = 1.8 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 4.62 (m, 1H), 3.88 (s, 1H), 3.48 – 
3.21 (m, 6H), 3.17 (t, J = 6.2 Hz, 2H), 2.41 (t, J = 6.5 Hz, 2H), 1.30 (d, J = 6.1 Hz, 6H), 




144.19, 126.43, 123.38, 114.65, 114.13, 75.86, 73.18, 68.48, 38.90, 38.59, 35.50, 35.35, 
28.07, 21.21, 20.47, 19.11 
(R)-S-pantetheinyl-4-amino-3-(tert-butoxy)benzothioate (2-24c) 
Compound 2-24c was prepared by the above procedure from 4-amino-3-(tert-
butoxy)benzoic acid 2-33c. 1H NMR (400 MHz, MeOD) δ 7.65 (dd, J = 8.4, 2.0 Hz, 
1H), 7.59 (d, J = 2.0 Hz, 1H), 6.88 (d, J = 8.5 Hz, 1H), 3.92 (s, 1H), 3.49 – 3.32 (m, 6H), 
3.20 (t, J = 6.2 Hz, 2H), 2.44 (t, J = 6.5 Hz, 2H), 1.41 (s, 9H), 0.83 (d, J = 14.1 Hz, 6H). 
13C NMR (101 MHz, MeOD) δ 193.19, 175.05, 174.06, 148.38, 140.87, 125.93, 125.41, 
122.52, 115.25, 82.68, 75.84, 68.48, 38.89, 38.61, 35.51, 35.36, 28.08, 27.86, 20.50, 
19.14. 
 (R)-S-pantetheinyl-4-amino-3-(sec-butoxy)benzothioate (2-34d) 
Compound 2-22d was prepared by the above procedure from 4-amino-3-(sec-
butoxy)benzoic acid 2-33d. 1H NMR (400 MHz, MeOD) δ 7.48 (dd, J = 8.3, 1.8 Hz, 
1H), 7.38 (d, J = 1.7 Hz, 1H), 6.71 (d, J = 8.3 Hz, 1H), 4.40 (m, 1H), 3.92 (s, 1H), 3.58 – 
3.37 (m, 6H), 3.16 (t, J = 6.6 Hz, 2H), 2.44 (t, J = 6.6 Hz, 2H), 1.82-1.64 (m, 2H), 1.33 
(d, J = 6.1 Hz, 3H), 1.03 (t, J = 7.5 Hz, 3H), 0.94 (s, 6H). 13C NMR (101 MHz, MeOD) δ 
189.63, 174.62, 172.51, 144.87, 144.07, 125.29, 122.32, 112.41, 111.11, 75.98, 75.79, 
69.01, 39.11, 38.95, 35.03, 34.36.95, 28.76, 27.51, 19.89, 19.53, 18.15, 8.63. 
2.4.9. Synthesis of AMB-CoA analog 2-27 
4-amino-3-methoxybenzoic acid 2-34 (1.4 mg, 8.7 µmol), coenzyme A (sodium 
salt hydrate, 9 mg, 13 µmol), and benzotriazol-1-yl-oxytripyrrolidinophosphonium 




tetrahydrofuran/ddH2O (1:1, v/v). N,N-Diisopropylethylamine (DIPEA, 15 µL, 87 
µmol) was added, the reaction mixture was stirred at 25 °C for 2 h. and then lyophilized. 
The dried product was resuspended in 10% aqueous acetonitrile and purified by 
preparative HPLC. The product-containing fractions were combined and lyophilized 
yielding AMB-CoA 2-27 as a white solid. 1H NMR (400 MHz, D2O) δ 8.45 (s, 1H), 8.10 
(s, 1H),  7.37 (dd, J = 8.3, 1.6 Hz, 1H), 7.21 (d, J = 1.6 Hz, 1H), 6.70 (d, J = 8.3 Hz, 1H), 
6.06 (d, J = 5.6 Hz, 1H), 4.75, 4.55 (m, 1H), 4.23 (m, 2H), 4.00 (s, 1H), 3.85 (s, 3H), 
3.82 – 3.43 (m, 6H), 3.18 (m, 2H), 2.43 (m, 2H), 0.89 (s, 3H), 0.75 (s, 3H). 13C NMR 
(101 MHz, D2O) δ 192.92, 174.78, 174.09, 155.40, 152.65, 146.42, 143.10, 139.66, 
126.07, 122.86, 113.91, 108.95, 86.60, 74.01, 71.97, 55.84, 38.96, 38.43, 35.44, 28.04, 
23.28, 20.94, 18.25. 
2.4.10. Overexpression and purification of CysG1 
CysG1 (adenylation domain and peptidyl-carrier-protein of CysG module 5, 
(Baumann et al., 2014) was cloned into a pHisTEV plasmid (derived from pET30a). 
Single colony transformants of E. coli BL21(DE3) carrying pHisTEV-CysG1 were 
grown aerobically for 12-15 h at 37 °C in 10 mL of LB medium supplemented with 50 
µg/mL kanamycin (LB-kan). Cells from the starter culture were added to 1 L of LB-kan, 
and the culture was grown aerobically at 37 °C until the A600 was 0.6-0.8. Expression 
was induced by the addition of 1 mM IPTG and the culture was grown aerobically at 15 
°C for an additional ~ 20 h. Cells were harvested by centrifugation. The medium was 
discarded and the cell paste was stored at –80 °C until use. Cells were thawed, 




NaCl), and then lysed by sonication on ice for 6 × 20 s using a Misonix Sonicator 3000 
(24 W, 1.5 s pulse, 1.5 s pause). Cell debris was removed by centrifugation and the 
lysate was loaded onto a Histrap column pre-equilibrated with lysis buffer. The column 
was washed with 5-10 column volumes of wash buffer (100 mM Tris-HCl, 30 mM 
Imidazole, pH 7.5). The protein was then eluted using elution buffer (100 mM Tris-HCl, 
300 mM NaCl, 250 mM imidazole, pH 7.5). Brown colored fractions containing the 
desired protein were pooled and buffer exchanged to final buffer (100 mM Tris-HCl, pH 
7.5 at 25 °C, 30% glycerol) via Econo-Pac 10DG size exclusion chromatography. The 
purified enzyme was stored in liquid nitrogen. Protein concentration was measured by 
the absorbance at 280 nm (A280) with an extinction coefficient calculated using the 
ProtParam tool of the ExPASy proteomics server. 
2.4.11. Chemoenzymatic synthesis of the 4-amino-3-methoxybenzoate (AMB) 
CysG1 thioester 2-28 
A typical enzymatic reaction for synthesizing the AMB CysG1 thioester 2-28 
was performed in 100 mM phosphate buffer, pH 7.5 containing the Svp 
phosphopantetheinyl transferase (20 µM), CysG1 (43 µM), AMB-CoA (0.3 mM) and 
MgCl2 (10 mM). The reaction was allowed to proceed aerobically at room temperature 
for about 6 hrs and was quenched by desalting using a Bio-spin 6 column (Bio-Rad). 
Then the sample was injected onto a reverse phase HPLC Zorbax 300SB-C8 3.5µ, 
3×150 mm column operating at room temperature coupled to an ESI-TOF mass 
spectrometer operating in positive ionization mode. LC-MS analysis of the reaction 








Figure 2.18 MS analysis of AMB-CysG1 thioester 2-28. A: CysG1 thioester 2-28 
(calculated monoisotopic mass: 73189.7 Da, experimental mass: 73190.6 Da) and B: 
CysG1 without modification (calculated monoisotopic mass: 72700.5 Da, experimental 
mass: 72699.3 Da). 
 
2.4.12. Reconstitution of the CysS-catalyzed methyl transfer reaction 
AMB-CysG1 thioester (53 µM), prepared as described above, was buffer 
exchanged into anaerobic 100 mM phosphate buffer, pH 7.5 using a Bio-spin 6 column 
in a glove box and then treated with 0.28 mM MeCbl, 0.56 mM SAM and 0.6 mM 
methyl viologen, 1.8 mM NADPH and 22 µM CysS or 44 µM CysS (The formation of 




allowed to proceed anaerobically at room temperature for about 14 hrs. The protein in 
the reaction mixture was desalted using 30K Amicon Ultra-0.5 mL centrifugal filters. 
LC-ESI-TOF-MS on protein samples was performed using an Agilent 1260 
HPLC system equipped with a binary pump and a 1200 series diode array detector 
followed by a MicroToF-Q II mass spectrometer (Bruker Daltonics) using an ESI source 
in positive mode. The analysis was performed on a Zorbax 300SB-C8 column (3 ×150 
mm column, 3.5 µm particles, Agilent). 
LC conditions: A- 0.1 % formic acid in H2O, B- 0.1 % formic acid in acetonitrile 
LC method: 0 min – 90% A, 10 min – 80% A, 25 min – 10% A 90% B, 27 min – 
90% A, 30 min – 90% A. 
The mass spectrometer parameters for protein analysis: Capillary, 4500 V; end 
plate offset, 500 V; nebulizer gas, 3.0 bar; dry gas, 10.0 L/min; dry gas temperature, 
220°C; funnel 1 RF, 400.0 Vpp; funnel 2 RF, 250 Vpp; quadrupole, Ion energy, 4.0 eV; 
low mass, 200 m/z; collision cell, collision energy, 8.0 eV; collision RF, 1000.0 Vpp; 
transfer time, 120.0 µs; prepulse storage, 10.0 µs. Data were processed with 





3. MECHANISTIC STUDIES OF SEQUENTIAL METHYLTIONS BY CysS*2 
 
3.1. Introduction 
Methylation has played a crucial role in many biological processes. The classic 
nucleophilic substitution is well established to generate the methylated product. There is 
not much known for the methylations at non-nucleophilic centers in numerous natural 
products, which have been recently found to be catalyzed by the enzymes in the radical 
SAM superfamily. Among them, cobalamin-dependent radical SAM methyltransferases 
can catalyze unusual methylations on diverse classes of substrates, including sp2-
hybridized, sp3-hybridized carbon atoms, and phosphinate phosphorous atoms.20 
Although, they are widespread in nature and have been first discovered in 1995,58 it was 
not until recently more and more enzymes in this class have been reconstituted in vitro, 
such as PhpK for the phosphinic acid P-methylation59, GenK and Fom3 for the alcohol 
C-methylation26, 28, ThnK for the iterative C-methylation to form the ethyl group30, TsrM 
for the aromatic C-methylation32, PoyC for the valine residue C-methylation33 (Figure 
3.1). However, details of mechanistic studies are still hindered because of the poor 
activity of the protein and substrates complexity.  
                                                
* Wang, Y.; Begley, T. P. Mechanistic studies of cobalamin dependent radical SAM enzyme CysS. 






Figure 3.1 Selected secondary metabolites whose biosynthesis include class B RSMTs 
that have been reconstituted in vitro. Carbon atoms that are introduced by class B 
RSMTs are highlighted by red. 
 
After it is shown that CysS can perform sequential methylations on a methyl 
group to form ethyl, isopropyl, sec-butyl, and t- butyl groups on p-aminobenzoate 
thioester by a radical mechanism in vitro, other combinations on methyl group of p-
aminobenzoate thioester in cystobactamids analogs were also explored. At first, only 
isopropoxylation was discovered on the 3-hydroxy-4-aminobenzoic acid moieties in the 
antibiotic cystobactamids from Cystobacter sp.51 Later, ethyl and sec-butyl groups in 
addition to the isopropyl group were also found in the new cystobactamids derivatives. 60 
Some of these new derivatives display significantly improved antibacterial activities in 
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these modifications occur in nature will help us better understand the structure–activity 
relationships of antibiotic discovery.  
A mechanism is proposed for CysS in Figure 3.2. After initial formation of 
methylcobalamin by SAM mediated methylation, a second SAM is reductively cleaved 
by the [4Fe− 4S]+1 cluster to generate the 5′-dA •. This 5′-dA • abstracts a hydrogen 
atom from the methyl group of the substrate 2-23 to give the substrate radical 2-25, 
which then undergoes a radical substitution with methylcobalamin to give the ethyl ether 
2-24a. Regeneration of MeCbl from Cbl(II) can be achieved by reduction to Cbl(I) by 
the [4Fe−4S]+1 cluster followed by SAM-mediated methylation. Repetition of this 
sequence results in the successive formation of the isopropyl, t-butyl, and sec-butyl 






Figure 3.2 Proposed mechanism for CysS-catalyzed iterative methylations. 
 
Because of the poor activities from the inclusion bodies and substrate 
complexities, detailed mechanism studies were not available for B12-dependent radical 
SAM methyltransferase, except for few stereochemistry studies26-29. Here, we are able to 
use a radical clock probe to trap the substrate radical and estimate the radical substitution 
of a methyl group from cobalamin in the mechanism. A brominated substrate analog is 
designed to trap the Cbl(I) intermediate, which is the critical species for the regeneration 
of MeCbl during each turnover. The resulting crosslinking species also provides useful 












































































































































and intrinsic isotope effects were also obtained to investigate the transition step of 
hydrogen abstraction step during the reaction. 
3.2. Result and discussion 
3.2.1. Measure methyl transfer rate with a radical clock probe  
During the CysS catalytic cycle, it is proposed that the substrate radical can 
undergo a radical substitution with methylcobalamin to give the methylated product. 
Since all the classic B12-dependent methyltransferases go through nucleophilic attack of 
the substrate to get methylated, the racial mechanism proposal was considered 
speculative for a long time. Even though such methyl group transfer from MeCbl to a 
carbon-based radical exists in cobalamin model studies and radical substitutions are 
widely used in organic synthesis, there is no such precedent of a radical species get 
methylated by MeCbl for the B12-dependent methyltransferases in nature until more and 
more B12-dependent radical SAM enzymes were discovered recently. For GenK, both 
nucleophilic and radical mechanism are proposed for the methyl group transfer from the 
MeCbl to the substrate and currently there is no experimental evidence that can 
distinguish them. But for ThnK, Fom3, and PoyC, it’s more likely that radical 
mechanism is responsible for the methylation of the substrates.  
    In order to probe the radical substitution step for methylation, a cyclopropyl 
analog 2-41 was designed. The ring opening by the cyclopropylcarbinyl radical is a well-
known fast radical reaction, which has been used as a radical trap and a measurement of 
the unknown rate in many competition reactions. The reported cyclopropylcarbinyl 




When cyclopropyl analog was incubated with CysS, SAM, MeCbl, MV and NADPH, 
LC-MS analysis of the CysS reaction mixture showed the formation of one of the new 
products had a mass corresponding to the methylated product 2-43, which was 
confirmed by the synthetic standard (Figure 3.3A, B). A large amount of 5′-dA 
formation was also observed in the same reaction when compared with the no substrate 
control, which further demonstrated the cyclopropyl analog was accepted as a substrate 
for CysS. When the reaction mixture was treated with 1% TFA, the ring opening derived 
product aminophenol compound 2-46 was detected by LC-MS (Figure 3.3C). The ratio 
of the methylated compound 2-43 and aminophenol compound 2-46 was quantified by 
using the authentic standard as 12.0. If we use the literature reported value (2 × 107 s−1) 
to estimate the value of the ring opening rate constant of the cyclopropyl substrate 2-41 
(kring), we can obtain the rate constant of the methyl group transfer from MeCbl to 
substrate radical (kme) based on the ratio of the final products 2-43 and 2-46. The 
estimated kme is around 2.4 × 108 s−1, which has never been estimated before. Since the 
cyclopropyl analog is a methoxybenzothioate derivative instead of a simple methoxy 
group as in the reference reaction and there might be a conformational restriction at the 
enzyme active site to create stereoelectronic effects, the exact ring opening rate constant 
of cyclopropyl analog would be lower than 2 × 107 s−1. Thus, the rate constant of the 
methyl group transfer by radical substitution could be lower than 2.4 × 108 s−1. 
Nevertheless, the methyl transfer rate constant is comparable with the ring opening rate 
constant of cyclopropyl analog 2-43. In solution chemistry, it’s reported that a ((6-iodo-




intramolecular homolytic substitution reaction at silicon (SHi) to form a cyclic five-
membered alkoxysilanes and a trimethylstannyl radical at a rate constant as 1 × 107 s−1.61 
The radical substitution rate constant could be larger when the bond orientation is 




Figure 3.3 CysS catalyzed reaction with cyclopropyl analog, extracted ion 
chromatograms (EICs) of the methylated cycropropyl product 2-43 [M + H]+ (482.23 ± 
0.02) for (A) Synthetic standard;  (B) CysS catalyzed reaction; EICs of the ring opening 
derived product 2-46 [M + H]+ (414.17 ± 0.02) for (C) CysS catalyzed reaction; (D) 
Synthetic standard; (E) Mass spectrum of the methylated cyclopropyl product 2-43 in 
CysS catalyzed reaction (Exact mass: 482.2319, Accuracy: <1 ppm); (F) Mass spectrum 
of the ring opening derived product 2-46 in CysS catalyzed reaction (Exact mass: 
414.1693, Accuracy: 3.6 ppm); (G)  Strategy for measuring the methyl transfer rate 

























































Figure 3.3 continued 
 
3.2.2. Trapping a Cbl(I) intermediate by brominated substrate analog 
Since the rate of the methyl transfer from Cbl to the substrate is very fast, we can 
expect that the carbon atom from the methoxyl group of the substrate should be in close 
vicinity of the carbon from the MeCbl. As we proposed Cbl(I) species is formed for the 
regeneration of the MeCbl (Figure 3.1) and Cbl(I) is known as a super nucleophile, if we 
replace the hydrogen on the methoxy carbon with a good leaving group, like a bromide, 
Cbl(I) can have a nucleophilic substitution to form a cobalamin substrate cross-linking 
species (Figure 3.4A). In order to explore this idea, brominated substrate analog 2-49 
was synthesized and was first tested in the model reaction to investigate whether Cbl(I) 
can react with brominated substrate analog 2-49 to generate the cross-linking species. 
Cbl(I) was first chemically reduced from Cbl(III) by using an excess of NaBH4 
anaerobically, indicated by the UV spectrum (Figure 3.5). When brominated substrate 













































changed from light gray to pink, which suggested a Cbl(III) species was formed. Further 
HPLC and LCMS analysis of the reaction mixture revealed the new species had a similar 
UV spectrum of Cbl(III) and had a MS corresponding to the Cbl crosslinking species 2-





Figure 3.4 (A) Strategy of developing the brominated substrate analog to trap Cbl(I) 
species (B) Model reaction for cobalamin cross-linking species through Cbl(I) 
2-49





























































Figure 3.5 UV spectrum of monitoring the chemical reduction of from Cbl(III) to Cbl(I)  
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more NaBH4
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Figure 3.6 Upper panel: MS of the substrate cobalamin adduct 2-50 in the model 
reaction; lower panel: MS/MS of the substrate cobalamin adduct 2-50 in model reaction  
 
Then, brominated substrate analog 2-49 was incubated with CysS, OHCbl, MV, 
NADPH, a new peak was detected by LC-MS, which has a MS corresponding with the 
Cbl substrate crosslinking species 2-50 (Figure 3.7B). This peak is absent when CysS, 
Cbl, 2-49 was excluded in the enzymatic reaction (Figure 3.7A). Also, the new peak had 
the same retention time, MS and MS/MS spectrum as the compound 2-50 formed in the 






























































































Figure 3.7 CysS-catalyzed reaction with brominated analog 2-49. (A) LCMS analysis of 
the CysS reaction with brominated analog. EICs of the adduct 2-50 [M + 2H]2+ (805.84 
± 0.02), red trace represents full reaction; green, black, blue, pink and black trace 
represent the full reaction without SAM, substrate, CysS, OHCbl and reducing system, 
respectively. (B) Mass spectrum of the adduct 2-50 in CysS catalyzed reaction (Exact 
mass: 805.8464, Accuracy: 9.4 ppm). (C) Structure of the Cbl substrate crosslinking 
species 2-50 (D) Different products generated from the crosslinking species under light 
condition or with NaCN. 
57 
Figure 3.8 LC-MS detection of the CysS-catalyzed reaction with brominated analog 2-49 
and the model reaction. EICs of the substrate cobalamin crosslinking adduct 2-50 [M + 
2H]2+ (805.84 ± 0.02). 
Figure 3.9 LC-MS detection of the CysS-catalyzed reaction with brominated analog 2-49 
and the model reaction.  (A) MS spectrum at 24 min. (B) Mass fragments of 805.84. 
To further confirm the formation of the carbon cobalt covalent bond, the 
enzymatic reaction was exposed to the light (Figure 3.7D). After light treatment, the 










































































amount of the substrate Cbl crosslinking species 2-50 decreased while the intensity of 
several peaks was increased (Figure 3.10).  
Figure 3.10 UV spectrum of CysS catalyzed reaction with (blue) and without (red) 
exposure to light. 
By co-elution experiment with the synthetic standard, the peak at 21 minute 
corresponds to aminophenol compound 2-52 and the peak at 25 minute corresponds to 
the ethyl compound 2-21(Figure 3.11).  Since carbon cobalt is considered weak, under 
the light condition, the carbon cobalt bond can go through homolytic cleavage to form 
ethyl radical 2-51, which either have a beta scission to form aminophenol compound 2-
52 or abstract a hydrogen atom to form the ethyl compound 2-21(Figure 3.7D). In order 
to test whether the radical abstract a hydrogen atom from the solvent, the reaction was 
performed in D2O. Compared with the H2O buffer, M+1 peak of 2-21 has increased from 
19% to 65% of the M peak (Figure 3.12).  


















Figure 3.11 LC-MS detection of 2-52 in the CysS reaction using brominated analog 2-49 
as substrate. (A) EICs of the aminophenol compound 2-52 [M + H]+ (255.08 ± 0.02). (B) 
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Figure 3.12 LC-MS detection of the ethyl compounds in CysS reaction using brominated 
analog 2-49 as substrate.  (A) EICs of the ethyl compound 2-21 [M + H]+ (283.11 ± 
0.02). (B) Mass spectrum of the ethyl compound 2-21 in H2O buffer. (C) Mass spectrum 
of the ethyl compound in D2O buffer 
 
The reaction mixture was also derivatized by adding cyanide (Figure 3.7D). 
Complete consumption of the crosslinking species 2-50 was detected with the formation 
of the aminophenol compound 2-52 and cyanide cobalamin (CN-Cbl) by HPLC (Figure 
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Figure 3.13 HPLC spectrum of derivatization of CysS catalyzed reaction using 
brominated analog 2-49 as substrate by cyanide 
 
In methionine synthase, Cbl(I) is the active species for the methyl transfer. Since 
we are not able to detect Cbl(I) by UV during the CysS reaction, it implies that Cbl(I) 
was transient and strongly coupled with the methyl transfer, which has also been 
observed for methionine synthase. However, we are able to design an electrophile Br-
NAC 2-49 to trap the nucleophile Cbl(I) species in the CysS active site. In CysS, Cbl(I) 
is also responsible for the regeneration of MeCbl using SAM as a methyl donor. 
 Here, Cbl(I) is methylated by Br-NAC 2-49 instead of SAM in the native 
reaction. This suggests that Br-NAC 2-49 is a better substrate for Cbl methylation than 
SAM, and the ethyl group of 2-49 is closer to cobalt than the methyl group of SAM, or it 
blocks SAM to methylate Cbl in a certain amount of time. Since a large amount of 5′-dA 

































was not detected when Br-NAC 2-49 was used as a substrate for CysS, it indicated that 
radical chemistry was not favored unless the MeCbl was formed. When Cbl substrate 
crosslinking species was incubated with SAM, CysS and the reducing system, an 
increased amount of 5′-dA was detected (not as much as the native substrate). This 
indicated that radical chemistry was not initiated until the Cbl gets methylated, and the 
substrate is present. However, the binding affinity of the Cbl substrate crosslinking 
species probably is not as good as the native substrate. That’s why following radical 
mediated methylation step was not observed for the brominated substrate analog. The 
Cbl substrate crosslinking species closely mimics the conformation when the methyl 
substrate is methylated by MeCbl to form ethyl group and suggests that the substrate is 
situated between MeCbl and SAM (Figure 3.14).  
 
 




























3.2.3. Identification of physiological cobalamin cofactor for CysS 
As MeCbl can be regenerated in enzyme active through Cbl(I) species, we are 
wondering whether MeCbl function as an enzyme cofactor or a substrate for CysS. 
CD3Cbl was synthesized and incubated with CysS, SAM, MV, NADPH. Unexpectedly, 
a majority of the methyl group was deuterium labeled even under single turnover 
condition (Figure 3.15). Furthermore, when CD3SAM was used with an excess of 
CH3Cbl, 76% of isopropyl product was deuterium labeled (When mixed MeCbl and 
OHCbl were used with CD3SAM, the percentage of deuterium incorporation will 
increase with the increased amount of OHCbl). It was found that OHCbl can be reduced 
to Cbl(II) more readily by MV, NADPH than MeCbl. These results indicate that CysS 
prefer the non-methylated Cbl than the methylated Cbl. CysS can perform sequential 
methylations with a catalytic amount of Cbl, which suggests that MeCbl is regenerated 
in situ in the enzyme active site. A SN2 mechanism requires in-line geometry of the 
methyl group donor- SAM and the methyl group acceptor-Cbl. Br-NAC 2-49 analog can 
also have a similar methyl transfer reaction, which suggests that the substrate and SAM 
probably share one binding site in at least one of the conformation. Thus, it’s very likely 
that SAM first methylates Cbl and then the substrate enters into the enzyme active site 
followed by the hydrogen abstraction, methylation. Then, the methylated substrate left 
the active site or have a substantial conformational change to allow the methyl group of 






Figure 3.15 CysS catalyzed methylation with (A) CD3Cbl, SAM (top) or CD3 SAM, 
CH3Cbl (bottom) in the presence of reducing system. (B) MS spectrum of the isopropyl 
product when CD3Cbl, SAM was used. (C) MS spectrum of the isopropyl product when 
CD3 SAM, CH3Cbl was used. 
 
3.2.4. Measurement of the competitive and intrinsic isotope effect 
The vast majority of radical SAM enzymes are known for generation of 5′dA•, 
which can abstract a hydrogen atom from the substrate. Isotope effects have been used as 










































































pantethinyl substrate 2-53 was synthesized and mixed with its protium substrate 2-23 in 
1:1 ratio in order to measure the intermolecular isotope effect. The enzymatic reaction 
was quenched at different time point (10 mins, 30 mins, 1h, 2.5h, 4h, 5.5h) and then 
analyzed by LC-MS/MS. The ratio of the methylated protium products 2-24a and the 
methylated deuterium product 2-54 was measured and the competitive isotope effect is 
17 ± 0.3.  
 Usually, the kinetic isotope effect can be masked by slower chemical steps 
which are not isotope-sensitive and by slow product release. In order to obtain the 
intrinsic isotope effect for hydrogen abstraction, CD2H-pantetheinyl substrates 2-55 
were synthesized. Here, we assumed that the three hydrogens on the methyl group could 
rotate freely in the enzyme active site and substitutions with deuterium will not have a 
significant effect. The KIE for CD2H-pantetheinyl substrates 2-55 was 18 ± 0.6 
measured based on the products ratio (Figure 3.16). The large intermolecular isotope 
effect indicates that the C-H bond breaking happens before or at the first irreversible step 
in the CysS enzymatic reaction. The small difference between intrinsic isotope effect and 
the intermolecular isotope effect also suggests that there is no slow step that precedes the 
hydrogen abstraction step. Furthermore, all isotope effects are larger than the 
semiclassical limit predicted by transition state theory. Such large kinetic isotope effects 
are often interpreted as an indication of quantum mechanical tunneling of the hydrogen 
atom. This kind of substantial isotope effects has also been reported for other radical 
SAM enzymes in the literature, like lipoyl synthase, biotin synthase (Figure 3.17).62-63 In 




sulfur atoms at C6 and C8 of an (N6-octanoyl)-lysyl residue on a lipoyl carrier protein 
(LCP) in the final step of lipoyl cofactor biosynthesis. When 8,8,8-trideuterooctanoyl 
peptide was used as a substrate for LipA, a large isotope effect was observed with only 
minute quantities of the lipoyl product which the C8 hydrogen is abstracted64. Because 
of this significant isotopic discrimination, Booker’s group was able to trap a covalent 
cross-link intermediate between the peptide and LipA before the second hydrogen 
abstraction from C865. 
 
 






























































Figure 3.17 (A) LipA in the biosynthesis of lipoic acid; (B) The conversion of 
dethiobiotin to biotin catalyzed by biotin synthase (BioB).  
 
3.2.5. Efforts to obtain a crystal structure of CysS 
Currently, no crystal structure is published for the B12 dependent radical SAM 
methyltransferase. The crystallography studies of CysS is collaborated with Dr. Drennan 
lab. From the size exclusion column analysis of purified CysS, it’s found that when 
CysS is overexpressed and purified in E. coli B12, CysS can easily aggregate to form 
dimers, trimers until hexamers in solution. In order to solve the heterogeneous problem, 
different constructs were made for CysS, including cleavable His tag site on both C- 
terminal and N-terminal of the protein, a SUMO tagged and a C-terminal truncated 
version of CysS. We also overexpressed and made the peptide carrier protein CysG1 and 
native substrate of CysS – small molecule modified CysG1 to co-express or incubate 
with CysS in order to get homogeneous protein for crystallography studies. The best 





























transport system in E. coli, developed by Dr. Booker.24 The cobalamin content and 
monomer species of CysS were increased. The crystallography studies are still in 
progress.  
3.3. Conclusion 
Based on the above result, we can build a detailed model of how CysS uses Cbl 
and radical SAM machinery to sequential methylate a methyl group to form ethyl, 
isopropyl, sec-butyl, and t- butyl groups (Figure 3.18). One molecule of SAM first binds 
to the [4Fe–4S] cluster in a conformation that can methylate Cbl. After the Cbl(I) is 
methylated by SAM via the SN2 mechanism, S-adenosyl homocysteine(SAH) is 
released. A second molecule of SAM binds to [4Fe–4S] cluster, because of the steric 
hindrance of MeCbl, the binding mode of the second molecule of SAM will be different 
from the first one, which favors the reductive cleavage and also opens up the active site 
for the binding of the substrate. Once the substrate enters into the active site, [4Fe–4S] 
cluster will cleave SAM to generate 5′-dA •, which abstracts a hydrogen atom from the 
methyl group of the substrate 2-23. The resulting radical 2-25 then undergoes a radical 
substitution with methylcobalamin to give the ethyl ether 2-24a. Regeneration of MeCbl 
from Cbl(II) can be achieved by reduction to Cbl(I) by the [4Fe−4S]+1 cluster followed 
by SAM-mediated methylation. Repetition of this sequence results in the successive 





Figure 3.18 Proposed model for CysS catalyzed sequential methylation.  
 
  Based on the isotope labeling cofactors experiment and Br-NAC 2-49 probe, we 
propose that Cbl is first reduced to Cbl(I) and then get methylated by SAM (Figure 
3.18A-B). No 5′-dA was detected when Cbl is absent in the reaction. The result of an 
increased amount of 5′-dA was detected when Cbl substrate crosslinking species was 
used as the substrate for CysS indicates that radical chemistry was not initiated until the 
Cbl get methylated, and the substrate is present. The formation of Cbl substrate 
crosslinking species 2-50 also suggests that the substrate is sandwiched between the Cbl 
cofactor and the radical SAM machinery (Figure 3. 18D-G), which is different from 























































































































































































GenK. For GenK, hydrogen abstraction is stereospecific and the methylation occurs with 
retention of configuration at C6′ of the substrate, which indicates MeCbl donor likely 
sits adjacent to the radical SAM machinery in the GenK active site. For Fom3, GenD1, 
and MoeK5, the methylations occur with inversion of configuration at the carbon center. 
These suggest that MeCbl and the radical SAM machinery are probably situated on the 
opposite sides of the center to be methylated once bound in the active site. Here, the Cbl 
substrate crosslinking species generated in the CysS active site instead of MeCbl further 
reassembles the geometry of substrates, cofactors in the later cases.  
 Based on our experimental results and OxsB crystal structure, SAM is proposed 
to have one binding site but two conformations for methyl transfer and radical initiation 
in CysS active sites (Figure 3. 18C-D). A radical clock probe is used to trap the substrate 
radical (Figure 3. 18F) and estimate the radical substitution rate of a methyl group from 
cobalamin for the first time. From the large competitive isotope effect, we know that 
CysS is a distributive rather than a processive enzyme, with the sequential reaction 
allowing free dissociation of the ethyl and isopropyl products.  
To conclude, we are able to develop different substrate analogs and isotope 
labeling compounds to trap important intermediates and build a model for the sequential 
methylation of CysS. It is known that the C-Co in MeCbl is considered weak (BDE: 
129.7kJ/mol). Thus, nature uses MeCbl as a catalyst to perform radical substitution for 
unusual methylation on sp3-hybridized carbon on substrate radical. Here, CysS is able to 
take advantage of these two complicated pieces of machinery- radical SAM and 




chemistry. The detail mechanistic study of CysS will help to unravel other 
methyltransferases in this large B12 radical SAM superfamily. 
3.4. Experimental methods 
3.4.1. Quantification of enzymatic products in the CysS catalyzed cyclopropyl 
substrate analog reaction  
A typical enzymatic reaction was performed in 100 mM phosphate buffer, pH 7.5 
containing 68 µM of CysS with 0.5 mM MeCbl, 0.5 mM SAM, 0.5 mM substrate with 
reducing systems (0.8 mM methyl viologen, 65 mM NADPH). The reaction was 
incubated at room temperature in an anaerobic chamber containing 95% nitrogen and 
5% hydrogen. For LC-MS analysis the enzyme was removed by ultrafiltration using a 
10kDa cut-off filter (VWR). The enzymatic assay was split into equal amounts.  One of 
them was used to quantified the methylated cyclopropyl product, the other half was used 
to quantify the ring opening derived product aminophenol compound by adding TFA 
(final concentration 0.1%). Calibration curves were constructed by measuring the peak 
intensity of synthetic standard 2-46 and 2-43 with known concentration using LC-MS. 
Then the calibration curves were used to measure the concentration of 2-46 and 2-43 in 
the enzymatic reaction. The ratio of the methylted products and the ring opening 
products is 12.0. If we used the literature reported value (2 × 107 s−1) to estimate the 
value of the ring opening rate constant of the cyclopropyl substrate (kring) in CysS 
reaction, we can calculate the rate constant of the methyl group transfer from MeCbl to 





Figure 3.19 calibration curves for the ring opening products and the methylated product 
 
3.4.2. Model reaction for generating the Cbl crosslinking species 2-50 
The preparation of Cbl(I) species is followed the protocol in the literature. A 
solution of hydroxocobalamin (50 mg) and cobalt nitrate (1 mg) in water (10 ml) is 
deoxygenated with a stream of argon. After 10 min a deoxygenated solution of sodium 
borohydride (15 mg) in water (1 ml) is added to the red cobalamin solution, which 
immediately turns brown and then blue-green, signifying that the reduction is complete. 
The reaction was also monitored by UV in anaerobic environment. 
3.4.3. Generation and derivatization of the Cbl crosslinking species in CysS 
catalyzed reaction 
90 µM of CysS was incubated with 1 mM MeCbl, 1 mM SAM, 1.2 mM Br-NAC 
2-49 with reducing systems (1.2 mM methyl viologen, 3.5 mM NADPH) at room 
temperature in an anaerobic chamber in dark for 12-15 hours. 
3.4.4. Measurement of the competitive isotope effect of CysS 
80 µM of CysS was incubated with 1 mM MeCbl, 1 mM SAM, 1 mM of 
87pantCH3 2-23 and 87pantCD3 2-53 with reducing systems (1 mM methyl viologen, 3 









































mM NADPH) at room temperature in an anaerobic chamber. The reaction was quenched 
at different time point (10 mins, 30 mins, 1h, 2.5h, 4h, 5.5h) by ultrafiltration using a 
10kDa cut-off filter. The reaction mixtures were analyzed by LC-MS/MS and the ratio 
of the methylated protium products 2-24a and the methylated deuterium 2-54 product 
was measured. Here, 10 min time point was used to obtain the competitive isotope 
effect, because after 10mins the dimethylated products can be detected by LC-MS/MS.  
3.4.5. Measurement of the intrinsic isotope effect of CysS 
20 µM of CysS was incubated with 270 µM MeCbl, 540 µM SAM, 540 µM of 
87pantCD2H with reducing systems (1 mM methyl viologen, 3 mM NADPH) at room 
temperature in an anaerobic chamber. The reaction was quenched at different time point 
(30 mins, 1h, 2h, 3h, 4h) by ultrafiltration using a 10kDa cut-off filter. The reaction 
mixtures were analyzed by LC-MS/MS and the ratio of the CDHMe products P1 and 
CD2Me products P2 was measured. Under this condition, the dimethylated products 
were not formed in 4 hours. After the natural abundance correction of stable isotopes, 



















methyl 3-(cyclopropylmethoxy)-4-nitrobenzoate (2-61) 
Diisopropyl azodicarboxylate (DIAD, 1.5 mmol) was added to the THF solution 
of triphenylphosphine (PPh3, 2.0 mmol) at 0° C. The reaction mixture was stirred for 
half an hour. Then to it cyclopropylmethanol (1.0 mmol) and methyl 3-hydroxy-4-
nitrobenzoate (1.0 mmol) were added one by one. It was then stirred at rt. in dark for 
overnight. Then it was concentrated and purified by column chromatography (Si-gel, 
25% ethyl acetate-hexane) to afforded 2-61. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 
8.3 Hz, 1H), 7.69 (m, 1H), 7.67 – 7.64 (m, 1H), 4.02 (d, J = 6.8 Hz, 2H), 3.93 (s, 3H), 
1.28 (m, 1H), 0.64 (m, 2H), 0.38 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 165.26, 



































4-amino-3-(cyclopropylmethoxy)benzoic acid (2-62) 
Using 10% Pd/C as catalyst, 50 mL of methyl methyl 3-(cyclopropylmethoxy)-4-
nitrobenzoate 2-62 (1.0 mmol) in methanol was pumped through the H-Cube®. The 
pressure of the system was set to full hydrogen mode, and the temperature to 35 °C. The 
flow rate was 0.8 mL/min. The fraction was analyzed using TLC, which showed 
complete conversion to the product, and the solvent was reduced to dryness, affording 
the 4-aminobenzoic acids. The resulting methyl 4-amino-benzoate (1.0 mmol) was 
suspended in 5M HCl (15 ml) and the mixture was heated at 60 °C. The reaction was 
monitored by TLC till completed. The reaction mixture was concentrated under vacuum 
and purified by column chromatography (silica gel, 40:1 CH2Cl2: MeOH) to give 2-62. 
1H NMR (400 MHz, CDCl3) δ 7.60 (dd, J = 8.2, 1.5 Hz, 1H), 7.44 (d, J = 1.4 Hz, 1H), 
6.66 (d, J = 8.2 Hz, 1H), 3.88 (d, J = 6.9 Hz, 2H), 1.30 – 1.25 (m, 1H), 0.62 (m, 2H), 
0.34 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 171.96, 145.42, 142.27, 125.06, 118.32, 






















D-pantethine (0.2 mmol) was reduced to D-pantetheine by addition of DTT (0.2 
mmol) and stirring for 1 h at room temperature. Water was removed by vacuum to leave 
a clear, viscous liquid. To a stirred solution of 4-amino-3-(cyclopropylmethoxy)benzoic 
acid 2-41 (0.4 mmol) in 3 mL of dichloromethane was added 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, 0.4 mmol), followed by 4-
dimethylaminopyridine (DMAP, 0.05 mmol) at room temperature. The resulting mixture 
was added to the pantetheine solution. The reaction was stirred at room temperature for 
overenight. All solvent was removed by vacuum and was purified by column 
chromatography (silica gel, 40:1 CH2Cl2: MeOH) to give 2-41. 1H NMR (400 MHz, 
MeOD) δ 8.19 (s, 1H), 7.94 (s, 1H), 7.50 (dd, J = 8.3, 1.9 Hz, 1H), 7.35 (d, J = 1.8 Hz, 
1H), 6.70 (d, J = 8.3 Hz, 1H), 3.94 – 3.87 (m, 3H), 3.44 (m, 6H), 3.16 (t, J = 6.6 Hz, 2H), 
2.43 (t, J = 6.6 Hz, 2H), 1.31 (m, 1H), 0.93 (s, 6H), 0.70 – 0.58 (m, 2H), 0.44 – 0.35 (m, 
2H). 13C NMR (101 MHz, MeOH) δ 189.61, 174.70, 172.60, 145.29, 144.14, 125.32, 
122.54, 112.20, 109.78, 76.00, 73.08, 69.03, 39.25, 38.96, 35.10, 34.98, 27.53, 19.91, 













3-(1-cyclopropylethoxy)-4-nitrobenzoic acid (2-63) 
3-fluoro-4-nitrobenzoic acid (1.0 mmol) and 1-cyclopropylethan-1-ol (1.1 mmol) 
are added to lithium bis(trimethylsilyl)amide (LiHMDS) (1M in THF, 1.1 ml) at 0 °C. 
KHMDS. 3.5 mL of LiHMDS solution was then added dropwise, resulting in a color 
change from light yellow to orange. This solution is stirred from 0 °C to room 
temperature over 2 h and then diluted with CH2Cl2 and washed once with saturated 
aqueous NH4Cl. The aqueous layer is back-extracted once with CH2Cl2. The organic 
layers are combined, dried over MgSO4, concentrated, and purified by column 































MeOD) δ 7.87 – 7.75 (m, 2H), 7.70 (m, 1H), 4.20 (dt, J = 12.5, 6.2 Hz, 1H), 1.44 (d, J = 
6.1 Hz, 3H), 1.14 (m, 1H), 0.57 (m, 2H), 0.36 (m, 2H). 13C NMR (101 MHz, MeOD) δ 
165.73, 149.90, 143.68, 134.46, 123.69, 120.82, 117.28, 79.95, 17.92, 15.42, 2.21, 0.24. 
 
4-amino-3-(1-cyclopropylethoxy)benzoic acid (2-64) 
Compound 2-64 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid 2-63. 1H NMR (400 MHz, MeOD) δ 7.55 – 7.42 (m, 
2H), 6.95 (m, 1H), 3.93 – 3.81 (m, 1H), 1.39 (dd, J = 6.1, 2.0 Hz, 3H), 1.14 (dt, J = 8.0, 
5.0 Hz, 1H), 0.58 – 0.48 (m, 2H), 0.41 – 0.24 (m, 2H). 13C NMR (101 MHz, MeOD) δ 
146.30, 144.19, 124.46, 123.80, 115.67, 113.07, 112.48, 79.38, 18.74, 16.41, 2.94, 0.88. 
 
(R)-S-pantetheinyl-4-amino-3-(1-cyclopropylethoxy)-benzothioate (2-43) 
Compound 2-43 was prepared by the above procedure for (R)-S-pantetheinyl-4-
amino-3-(cyclopropylmethoxy)-benzothioate 2-41. 1H NMR (400 MHz, MeOD) δ 7.49 
(dd, J = 8.3, 1.9 Hz, 1H), 7.39 (d, J = 1.8 Hz, 1H), 6.71 (d, J = 8.3 Hz, 1H), 3.92 – 3.84 
(m, 2H), 3.55 – 3.38 (m, 6H), 3.16 (t, J = 6.6 Hz, 2H), 2.43 (t, J = 6.6 Hz, 2H), 1.41 (d, J 


















(m, 2H). 13C NMR (101 MHz, MeOD) δ 189.57, 174.62, 172.51, 145.28, 144.17, 
125.27, 122.65, 112.81, 112.59, 79.41, 75.99, 69.02, 39.11, 38.96, 35.04, 34.96, 27.51, 
19.90, 19.55, 18.70, 16.36, 3.01, 0.86. 




methyl 3-(2-bromoethoxy)-4-nitrobenzoate (2-65) 
Compound 2-65 was prepared by the above procedure for methyl 3-
(cyclopropylmethoxy)-4-nitrobenzoate using 2-bromoethan-1-ol. 1H NMR (400 MHz, 
MeOD) δ 7.87 – 7.80 (m, 2H), 7.73 (m, 1H), 4.57 (t, J = 11.4 Hz, 2H), 3.94 (s, 3H), 3.75 
(t, J = 11.4 Hz, 2H). 13C NMR (101 MHz, MeOD) δ 172.95, 166.49, 152.06, 136.03, 
































4-amino-3-(2-bromoethoxy)benzoic acid (2-66) 
Compound 2-66 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid. 1H NMR (400 MHz, MeOD) δ 7.76 (m, 2H), 7.52 
(m, 1H), 4.3 (t, J = 11.4 Hz, 2H), 3.81 (t, J = 11.4 Hz, 2H).13C NMR (101 MHz, MeOD) 
δ  168.03, 152.58, 134.00, 125.04, 124.31, 124.13, 115.11, 53.04, 29.63.
 
S-(2-acetamidoethyl) 4-amino-3-(2-bromoethoxy)-benzothioate (2-49) 
To a solution of triethylamine (TEA, 1.0 mmol) in dichloromethane (3 mL) was 
added 4-amino-3-(2-bromoethoxy)benzoic acid 2-66 (0.5 mmol), (3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, 0.5 mmol), 1-
hydroxybenzotriazole (0.5 mmol) and N-acetylcysteamine (SNAC, 0.5mmol). The 
reaction mixture was stirred overnight under argon. The organic layer was washed with 
saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried over 
anhydrous sodium sulfate and concentrated under vacuum. Purification of the crude 
mixture by flash chromatography (silica gel, 1:1 to 2:1 of hexanes:EtOAc) afforded 2-















1H), 6.70 (d, J = 8.3 Hz, 1H), 4.34 (t, J = 11.4 Hz, 2H), 3.74 (t, J = 11.4 Hz, 2H), 3.38 (t, 
J = 6.7 Hz, 2H), 3.13 (t, J = 6.7 Hz, 2H), 1.92 (s, 3H). 13C NMR (101 MHz, MeOD) δ 
190.83, 173.45, 145.84, 145.75, 126.68, 124.63, 113.91, 111.95, 70.15, 40.54, 30.62, 
28.94, 22.51. 
3.4.9. Synthesis of (R)-S-pantetheinyl-4-amino-3-(methoxy- d3)-benzothioate 
 
 
3-(methoxy-d3)-4-nitrobenzoic acid (2-67) 
Compound 2-67 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid. 1H NMR (400 MHz, MeOD) δ 7.91 – 7.77 (m, 2H), 
7.70 (dd, J = 8.3, 1.5 Hz, 1H). 13C NMR (101 MHz, MeOD) δ 167.68, 153.46, 144.08, 



































4-amino-3-(methoxy- d3) benzoic acid (2-68) 
Compound 2-68 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid. 1H NMR (400 MHz, MeOD) δ 7.49 – 7.37 (m, 2H), 
6.68 (d, J = 8.2 Hz, 1H). 13C NMR (101 MHz, MeOD) δ 170.65, 147.41, 144.05, 125.58, 
119.55, 113.85, 112.29. 
 
(R)-S-pantetheinyl-4-amino-3-(methoxy- d3)-benzothioate (2-53) 
To a stirred solution of 4-amino-3-(methoxy- d3) benzoic acid 2-68 (0.5 mmol) in 
10 mL of dry THF was added N-hydroxysuccinimide (NHS) (0.5 mmol), followed by N, 
N'-Dicyclohexylcarbodiimide (DCC) (0.5 mmol) at room temperature. The resulting 
mixture was stirred overnight at room temperature. The white precipitate was filtered 
and then washed with EtOAc. The filtrate was concentrated under reduced pressure. The 
residue was triturated with CH2Cl2 to give the NHS ether of 2-68. Pantethine (0.075 
mmol), sodium bicarbonate (1.9 mmol), and 1,4-dithiothreitol (DTT) (0.08 mmol) were 
dissolved in 3 mL of water, and left to stand for 10 minutes to allow reduction of the 




















mL of tetrahydrofuran (THF) and added to the 3 mL water mixture. The reaction mixture 
was stirred overnight and then the solvent was evaporated under reduced pressure. The 
crude product was then dissolved in water and the insoluble residue was removed by 
filtration. The resulting solution was lyophilized and purified by flash chromatography 
(silica gel, 20:1 to 10:1 CH2Cl2: MeOH).  The fraction was further purified by Prep 
HPLC using a SPLC-18DB column (10 x 250 mm, 5 µm, Supelco) at a flow rate of 2 
mL/min on an Agilent 100 HPLC system with a quaternary pump and an automatic 
injector. 1H NMR (400 MHz, MeOD) δ 7.48 (dd, J = 8.3, 1.9 Hz, 1H), 7.35 (d, J = 1.9 
Hz, 1H), 6.66 (d, J = 8.3 Hz, 1H), 3.88 (s, 1H), 3.59 – 3.33 (m, 6H), 3.14 (t, J = 6.7 Hz, 
2H), 2.41 (t, J = 6.6 Hz, 2H), 0.91 (d, J = 1.4 Hz, 6H). 13C NMR (101 MHz, MeOD) δ 
191.00, 176.04, 173.92, 147.47, 145.35, 126.70, 123.97, 113.41, 109.57, 77.40, 70.43, 
40.54, 40.37, 36.45, 36.38, 28.91, 21.30, 20.95. 
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3-(methoxy-d2)-4-nitrobenzoic acid (2-69) 
Compound 2-69 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid. 1H NMR (400 MHz, MeOD) δ 7.86 – 7.79 (m, 2H), 
7.70 (dd, J = 8.3, 1.4 Hz, 1H), 3.96 (s, 1H).  
 
4-amino-3-(methoxy-d2) benzoic acid (2-70) 
Compound 2-70 was prepared by the above procedure for methyl 4-amino-3-
(cyclopropylmethoxy)benzoic acid. 1H NMR (400 MHz, MeOD) δ 7.50 – 7.35 (m, 2H), 
6.68 (d, J = 8.2 Hz, 1H), 3.82 (s, 1H). 13C NMR (101 MHz, MeOD) δ 170.90, 147.44, 




























Compound 2-55 was prepared by the above procedure for (R)-S-pantetheinyl-4-
amino-3-(cyclopropylmethoxy)-benzothioate using 4-amino-3-(methoxy- d2) benzoic 
acid. 1H NMR (400 MHz, MeOD) δ 7.51 (dd, J = 8.3, 1.9 Hz, 1H), 7.38 (d, J = 1.9 Hz, 
1H), 6.69 (d, J = 8.3 Hz, 1H), 3.91 (s, 1H), 3.88 – 3.84 (m, 1H), 3.57 – 3.38 (m, 6H), 
3.17 (t, J = 6.7 Hz, 2H), 2.44 (t, J = 6.7 Hz, 2H), 0.94 (d, J = 1.4 Hz, 6H). 13C NMR (101 
MHz, MeOD) δ 189.61, 174.63, 172.51, 146.06, 143.93, 125.29, 122.57, 112.01, 108.17, 
75.99, 69.02, 54.36, 54.14, 53.92, 39.13, 38.96, 35.04, 34.97, 27.51, 19.91, 19.54.  
3.4.11. Synthesis of S-(2-acetamidoethyl) 4-amino-3-hydroxybenzothioate (2-52) 
 
Compound 2-52 was prepared by the above procedure for S-(2-acetamidoethyl) 
4-amino-3-(2-bromoethoxy)-benzothioate using 4-amino-3-hydroxybenzoic acid. 1H 
NMR (400 MHz, MeOD) δ 7.72 – 7.63 (m, 1H), 7.63 – 7.48 (m, 2H), 3.46 (t, J = 6.7 Hz, 
2H), 2.81 (t, J = 6.7 Hz, 2H), 1.93 (s, 3H).  
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Compound 2-46 was prepared by the above procedure for (R)-S-pantetheinyl-4-
amino-3-(cyclopropylmethoxy)-benzothioate using 4-amino-3-hydroxybenzoic acid. 1H 
NMR (400 MHz, MeOD) δ 7.40 (dd, J = 8.3, 2.0 Hz, 1H), 7.31 (d, J = 2.0 Hz, 1H), 6.67 
(d, J = 8.3 Hz, 1H), 3.91 (s, 1H), 3.51 – 3.38 (m, 6H), 3.14 (t, J = 6.7 Hz, 2H), 2.43 (t, J 
= 6.7 Hz, 2H), 0.94 (s, 7H). 13C NMR (101 MHz, MeOD) δ 189.67, 174.63, 172.51, 
143.42, 143.02, 125.71, 121.23, 112.69, 112.22, 75.98, 69.01, 39.14, 38.95, 35.02, 








Iron is known to play a crucial role in the living system. Although iron is the 
fourth most common element in the Earth's crust, it is not readily bioavailable at neutral 
pH due to oxidation to the insoluble ferric oxide. For the soluble reduced Fe2+, it can 
catalyze the generation of toxic free radicals through Fenton chemistry. These reactive 
oxygen species (ROS) can react with membrane lipids, proteins, and nucleic acids, 
which cause irreversible cell damage.66 Thus, the free iron concentration has to remain 
very low. Mammals employ heme, iron-binding proteins (transferrin, lactoferrin) to 
reduce the levels of free extracellular iron to around 10−18 M, which is orders of 
magnitude below the 10−6 M required for bacterial growth.67 The majority of iron within 
the host, approximately 95%, is sequestered in the form of heme, primarily as 
hemoglobin.68 However, free heme is considered toxic to the cells.69 
In order to compete for the host’s iron during infection, pathogens have 
developed sophisticated mechanisms to utilize heme as a source of iron.67 Bacteria 
employ surface proteins to seize heme from hemoproteins and then shuttle heme across 
the outer-membrane/cell wall onto specific transporters for import across the 
cytoplasmic membrane.70 Inside the bacterial cell, heme is incorporated directly into 
proteins or it is further degraded to release the iron.71 Oxidative degradation by heme 




In most of the cases, heme oxygenase catalyzes oxidative cleavage of heme.72 
Heme oxygenase requires three molecules of oxygen and seven electrons to 
regiospecifically cleave heme at the a-meso-carbon to yield biliverdin IXa via a-meso-
hydroxyheme and verdoheme.73-75  
However, it’s known that pathogens can colonize the nonsterile region of the 
lower intestines, which is an anaerobic environment. For example, Vibrio cholerae and 
Escherichia coli O157:H7 are hemolytic enteric pathogens, and a bona fide heme 
oxygenase has not been characterized for them. Both organisms can use heme as an iron 
source and contain a heme uptake operon that is up-regulated during iron duress.76-77 
The heme uptake operon includes a heme uptake and transport machinery, and 
three additional genes, chuw, chux, and chuy (Figure 4.1). ChuW is assigned as a radical 
SAM enzyme and has high sequence similarity with coproporphyrinogen III oxidase 
(HemN), which is a characteristic feature of Class C radical SAM methyltransferases. 











In 2016, Dr. Lanzilotta demonstrates that ChuW is able to catalyze a radical-
mediated reaction to break the protoporphyrin ring of heme to release iron and form a 
tetrapyrrole product “anaerobilin” anaerobically (Figure 4.2).78 5′-dA and SAH were 
produced at 1:1 stoichiometry in the presence of heme, ChuW and flavodoxin, 
NADPH/flavodoxin reductase system. When [13C-methyl]- SAM was used in the assay, 
the isolated product exhibited an enrichment of 13C. This suggests that ChuW also 
catalyzes the transfer of a methyl group from the SAM moiety to the product. 
Furthermore, the anaerobilin can be used as a substrate by anaerobilin reductase ChuY in 
the same operon. Nevertheless, the deuteroheme-derived tetrapyrrole product 
deuteroanaerobilin (DAB) is not stable under the light condition. Exposure of DAB to 
sunlight for 5 min resulted in a significant change in the UV-visible spectrum. The light 























Here, we try to design substrate analogs to trap the possible racial intermediates 
generated on the tetrapyrrole ring during the ChuW catalyzed reaction in order to study 
the mechanism. 
4.2. Result and discussion 
4.2.1. Reconstitution of ChuW catalyzed heme degradation 
The chuW gene was obtained from Dr. Lanzilotta and was cloned into a pTHT 
vector. When heme was used as a substrate for ChuW with E. coli flavodoxin 
(EcFldA)/ferredoxin (flavodoxin): NADP+ oxidoreductase (EcFpr)/ NADPH system as 
the reducing system, a new species (455nm, 800nm) was formed similarly as the 
reported anaerobilin with heme degraded over time based on the UV spectrum (Figure 






Figure 4.3 UV spectrum of the time course of the ChuW catalyzed heme degradation. 
 
LC-MS analysis of ChuW degradation of heme reaction mixtures showed a large 

















Figure 4.4 LC-MS analysis of ChuW catalyzed heme degradation. Upper panel: EICs of 
5′-dA [M+H]+ (252.11±0.02). Lower panel: EICs of SAH [M+H]+ (385.12±0.02). 
 
HPLC analysis of ChuW degradation of heme reaction mixtures also showed 
formation of a new speak under 455 nm (Figure 4.5).  
 
 
Figure 4.5 HPLC analysis of ChuW catalyzed heme degradation. 







050617No Heme2_1-B,2_01_1233.d: EIC 385.1289±0.2 +All MS, Smoothed (2.51,1,GA) 050617 ChuWheme1_1-B,1_01_1232.d: EIC 385.1289±0.2 +All MS, Smoothed (2.32,1,GA)
050617No ChuW3_1-B,3_01_1234.d: EIC 385.1289±0.2 +All MS, Smoothed (2.38,1,GA)









050617No Heme2_1-B,2_01_1233.d: EIC 252.1091±0.02 +All MS 050617 ChuWheme1_1-B,1_01_1232.d: EIC 252.1091±0.02 +All MS, Smoothed (4.64,1,GA)
050617No ChuW3_1-B,3_01_1234.d: EIC 252.1091±0.02 +All MS





































LC-MS analysis of ChuW degradation of heme reaction mixtures showed the 
new peak of 455 nm had a mass of 577.28, which corresponds with the mass of the ring 
opening product anaerobilin (Figure 4.6). 
 
 
Figure 4.6 LC-MS analysis of ChuW catalyzed heme degradation. Upper panel: EICs of 
anaerobilin [M+H]+ (577.28±0.02). Lower panel: mass spectrum of anaerobilin at 15 
min. 
 
4.2.2. Design of cyclopropyl heme analog as a radical trap for ChuW catalyzed 
reaction 
Since there is one mass unit of 5′-dA increased from 11% to 60% when [d3-
methyl]-SAM was used in the chuW reaction, it’s proposed that 5′-dA generated from 
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SAM. The resulting SAM radical can attack the unsaturated bond on the porphyrin ring 
of heme. This resulting radical species can be delocalized on the porphyrin ring to 
initiate the ring cleavage and the methylation. Since the ring opening of the 
cyclopropylcarbinyl radical is a well-recognized fast radical reaction,79 the displacement 
of the vinyl group from the heme with a cyclopropyl group could be used to trap the 
radicals generated on the protoporphyrin ring.  
The functionalization of vinyl group of tetrapyrrolic ring has been explored 
extensively for new photosensitizer libraries.80 One of the useful functionalizations is a 
reaction with 1,3-dipolar compounds via a concerted cis-cycloaddition mechanism using 
diazomethane. The resulting 1-pyrazolines can be photolyzed or pyrolyzed to give 
cyclopropanes.81 Cyclopropyl heme analog 4-6 is synthesized using the literature route 





Figure 4.7 Synthetic route of cyclopropyl heme analog 
 
4.2.3. Cyclopropyl heme analog as a substrate for ChuW 
When cyclopropyl heme 4-6 was used as a substrate for ChuW with EcFldA/ 
EcFpr/ NADPH system as the reducing system, a new species (455nm, 780nm) was 
formed, which is blue shifted when compared with the anaerobilin based on the UV 











































Figure 4.8 UV spectrum of the time course of the ChuW catalyzed cyclopropyl heme 
degradation. 
 
LCMS analysis of ChuW degradation of cyclopropyl heme 4-6 reaction mixtures 
showed a large amount formation of 5′-dA in the reaction, which suggests that ChuW 
takes cyclopropyl heme as a substrate (Figure 4.9). 
 
 
Figure 4.9 LC-MS analysis of ChuW catalyzed cyclopropyl heme 4-6 degradation. EICs 






































HPLC analysis of ChuW degradation of cyclopropyl heme 4-6 reaction mixtures 
also showed the formation of new species which have an absorbance around 500nm. The 
high wavelength products are not stable under air and light condition. The 500nm 
products decrease over time (Figure 4.10). 
 
 
Figure 4.10 HPLC analysis of ChuW catalyzed cyclopropyl heme degradation under UV 
of 500 nm.  
 
LCMS analysis of new compounds with high wavelength showed a new peak of 
500 nm had a mass of 605.31, which corresponds with the mass of the methylated ring 














Figure 4.11 LC-MS analysis of ChuW catalyzed cyclopropyl heme degradation. Upper 
panel: EICs of [M+H]+ (605.31±0.02). Lower panel: mass spectrum of degradation 
product at 15 min. 
 
When CD3-SAM or 13CH3-SAM was used in the ChuW catalyzed cyclopropyl 
heme degradation reaction, there were two mass units and one mass unit increase in the 
605.31 peak respectively (Figure 4.12). This suggests that the methyl group is 
transferred to the new product from SAM. However, this compound is also not stable 
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Figure 4.12 Mass spectrum of ChuW catalyzed cyclopropyl heme degradation product at 
15 min with (A) CD3-SAM or (B) 13CH3-SAM. 
 
4.2.4. Detection of protoporphyrin ring opening product in ChuW catalyzed 
cyclopropyl heme 4-6 degradation 
Under the UV wavelength of 390 nm, there was a new peak formation around 34 
min in HPLC chromatography, which has a similar UV spectrum as the protoporphyrin 
(Figure 4.13). Because of the highly conjugated p-electron systems of the tetrapyrrole 
ring, the porphyrins have characteristic UV-visible spectra that consist of two distinct 
region regions: in the near ultraviolet and the visible region.82 The porphyrins display 
extreme intense bands, the so-called Soret or B-bands in the 380–500 nm range with 
molar extinction coefficients of 105 M-1 cm-1. Moreover, at longer wavelengths, in the 
500–750 nm range, the porphyrins spectra contain a set of weaker, but still considerably 






























































generated in the ChuW catalyzed cyclopropyl heme 4-6 degradation, it has a large 
absorbance around 390 nm in the Soret bands region, and some weaker absorbance in 
the 500, 530, 570 nm in the Q-bands region (Figure 4.13). This suggests that this new 
peak should still maintain the intact porphyrin ring. This product is considered stable 
under the light condition for several hours (Figure 4.14). 
 
 
Figure 4.13 HPLC analysis of ChuW catalyzed cyclopropyl heme degradation. Upper 
panel: HPLC UV trace of 390 nm. Lower panel left: UV spectrum of heme; Lower panel 






















Figure 4.14 HPLC analysis of stability of products in ChuW catalyzed cyclopropyl heme 
degradation over time under 400 nm 
 
LC-MS analysis of the new compound showed it had a mass of 591.3011, which 
corresponds with the mass of cyclopropyl heme analog without the iron (Figure 4.15B). 
When CD3-SAM was used in the ChuW catalyzed reaction, 60% of the product have one 
mass unit increased (Figure 4.15C). To further explore whether the cyclopropyl side 
chain is open, the porphyrin product was purified from HPLC and was hydrogenated in a 
short amount of time. A new peak with a mass of 593.31 was formed (Figure 4.15D). 
This suggests that there is a double bound on the side chain of the porphyrin ring and 












Figure 4.15 LC-MS analysis of ChuW catalyzed cyclopropyl heme degradation. (A) 
EICs of [M+H]+ (591.30±0.02). (B) Mass spectrum of the porphyrin degradation product 
at 19 min. (C) Mass spectrum of the porphyrin degradation product when the reaction 
used CD3-SAM as cofactor. (D) Mass spectrum of the porphyrin degradation product 





























































































































4.2.5. Detection of SAM adducts in ChuW catalyzed cyclopropyl heme degradation 
LC-MS analysis of the unstable high wavelength products showed a compound 
had a mass corresponding to the crosslinking species 4-10 between cyclopropyl heme 
derived product and SAM, which were absent in the control (Figure 4.16). Another 
compound also had a mass corresponding to the crosslinking species 4-11 between 
cyclopropyl heme derived product and methylthioadenosine (Figure 4.17). It is known 
that SAM can degrade to L-homoserine lactone (HSL) and 5-methylthioadenosine 
(MTA) under high and low pH condition.83 After purification and acid treatment of the 




Figure 4.16 LC-MS analysis of ChuW catalyzed cyclopropyl heme degradation. Upper 
panel: EICs of [M+2H]2+ (502.22±0.02). Lower panel: mass spectrum of the porphyrin 
cross-linking species 4-10 at 12.5 min. 









0718No ChuW P256p4_1-B,2_01_2200.d: EIC 502.2284±0.02 +All MS 0718ChuW P256p4_1-B,1_01_2201.d: EIC 502.2284±0.02 +All MS



















































Figure 4.17 LC-MS analysis of ChuW catalyzed cyclopropyl heme degradation. Upper 
panel: EICs of [M+H]+ (902.40±0.02). Lower panel: mass spectrum of the degradation 
porphyrin cross-linking species 4-11 at 13.5 min. 
 
When CD3-SAM was used in the reaction, the majority of the crosslinking 
species have 2-4 mass unit increased for the +1-charged compound (Figure 4.18, 4.19). 
Similarly, when 13CH3-SAM was used in the reaction, the majority of the crosslinking 
species have 2 mass unit increased for SAM adduct 4-10 (Figure 4.18, 4.19). MS/MS 
fragmentations of the crosslinking species also match with two methylene groups from 
SAM get incorporated into the product (Figure 4.20).  
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Figure 4.18 Mass spectrum of the porphyrin cross-linking species (503.22) when ChuW 
used (upper panel) CD3-SAM, (lower panel) 13CH3-SAM as cofactor.  
 
 
Figure 4.19 Mass spectrum of the porphyrin cross-linking species 4-10 (1003.45) when 
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Figure 4.20 Mass fragmentation of the porphyrin cross-linking species (502.23) when 
ChuW used (upper panel) CH3-SAM, (middle panel) CD3-SAM, (lower panel) 13CH3-










































































































Figure 4.21 Mass spectrum of the degradation porphyrin cross-linking species 4-11 
(902.40) when the ChuW used (upper panel) CD3-SAM, (lower panel) 13CH3-SAM as 
cofactor.  
 
When CD3-SAM was used as the cofactor and titanium citrate was used as the 
reducing agent in the ChuW catalyzed reaction, the [A+1] peak for 5'-dA increased from 
13% to 98% of [A], the [A+2] peak for 5'-dA increased from 1.8% to 31% of [A] 
(Figure 4.23). It’s been shown in the literature that 5'-dA radical can abstract a hydrogen 
atom from the second molecule of SAM (Figure 4.22). Thus, it’s expected that there will 
be 1 mass unit increased for the 5'-dA when CD3-SAM was used. However, the increase 
of [A+2] peak indicated that the ring opening radical probably could abstract a hydrogen 











































































Figure 4.23 Mass spectrum of 5'-dA when ChuW used (upper panel) CD3-SAM, (lower 
panel) 13CH3-SAM as the cofactor.  
 
4.2.6. ChuW catalyzed cyclopropyl protoporphyrin degradation 
Since protoporphyrin can also be a substrate for ChuW, cyclopropyl 


























































































for ChuW. LC-MS analysis of ChuW degradation of cyclopropyl protoporphyrin 
reaction mixtures showed a large amount formation of 5′-dA in the reaction, which 
suggests that ChuW takes cyclopropyl protoporphyrin as a substrate (Figure 4.24).  
 
  
Figure 4.24 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin 
degradation. EICs of 5'-dA [M+H]+ (252.10±0.02). 
 
 HPLC analysis of ChuW degradation of cyclopropyl protoporphyrin reaction 
mixtures also showed the formation of new species which have absorbance around 455 
nm (Figure 4.25). The high wavelength products are not stable under air and light 
condition. The 500nm products will decrease over time, which is similar to the case 
when cyclopropyl heme 4-6 is used as a substrate for ChuW. 
 


























Figure 4.25 HPLC analysis of ChuW catalyzed cyclopropyl protoporphyrin 4-12 
degradation under 455 nm UV. 
 
Similarly, as the cyclopropyl heme substrate, LC-MS analysis of high 
wavelength compounds showed a mass of 605.31, which corresponds with the mass of 
the ring opening product 4-7 (Figure 4.26). What’s more, a new peak with a mass of 
607.32 was also detected, which corresponds with the further reduced form of the ring 

















Figure 4.26 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin 
degradation. Upper panel: EICs of the ring cleavage product [M+H]+ (605.31±0.02). 
Lower panel: mass spectrum of the ring cleavage product 4-7 at 13 min. 
 
 
Figure 4.27 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin 
























































































(607.33±0.02). Lower panel: mass spectrum of the reduced form of ring cleavage 
product 4-13 at 12 min. 
 
Mass corresponding with the crosslinking species between cyclopropyl ring 
product and SAM was also detected (Figure 4.28). When CD3-SAM was used in the 
reaction, the majority of the crosslinking species 2-4 mass units increased for the SAM 
adduct 4-10 (Figure 4.29). When D4-SAM was used in the reaction, the crosslinking 
species also have 4 mass units increased for the SAM adduct 4-10 (Figure 4.29). The 




Figure 4.28 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin 
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Figure 4.29 Mass spectrum of the porphyrin cross-linking species (502.23) when the 
ChuW used (upper panel) CH3-SAM, (middle panel) CD3-SAM, (lower panel) D4-SAM 



























































































































Figure 4.30 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin 
degradation. Upper panel: EICs of the degradation product of porphyrin cross-linking 
species [M+H]+ (902.40±0.02). Middle panel: mass spectrum of the degradation product 
of porphyrin cross-linking species at 11.5 min; Zoon in graph: mass spectrum of the 
degradation product of porphyrin cross-linking species at 11.5 min when D4-SAM was 
used as cofactor; Lower panel: mass spectrum of the degradation product of porphyrin 
cross-linking species at 11.5 min when CD3-SAM was used as cofactor. 
 
When a strong reducing reagent, such as titanium citrate, was used in the ChuW 
catalyzed reaction, a crosslinking species 4-15 was detected with just one methylene 
group from SAM got incorporated (Figure 4.31). Based on the UV spectrum, the 
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crosslinking species most likely contains the ring opening form of the porphyrin ring. 
When CD3-SAM was used in the reaction, the majority of the crosslinking species have 
2 mass units increased, which suggested that there was one methylene group from the 
methyl group of SAM (Figure 4.32). 
 
Figure 4.31 LC-MS analysis of ChuW catalyzed cyclopropyl protoporphyrin degradation 
using titanium citrate as reducing agent. Upper panel: EICs of the cross-linking species 
[M+H]+ (888.38±0.02). Middle panel: UV spectrum of the cross-linking species at 11 
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Figure 4.32 Mass spectrum of the cross-linking species in ChuW catalyzed cyclopropyl 
protoporphyrin degradation using titanium citrate as reducing agent. 
 
4.2.7. Proposed mechanisms for the ring opening product of ChuW catalyzed 
cyclopropyl substrates reaction  
Based on the result that 5′-dA radical abstracts a hydrogen atom from a methyl 
group of SAM and the methylene group from SAM is transferred to the ring opening 
tetrapyrrole product in the ChuW catalyzed reaction, several mechanisms can be 
proposed for the formation of protoporphyrin ring opening product 4-9. Here, two 
mechanisms are shown in Figure 4.33 and Figure 4.34.  After 5′-dA radical abstracts a 
hydrogen atom from a methyl group of SAM, the SAM radical attacks the unsaturated 
bond of the 4-6 to form 4-21. In pathway a, deprotonation and tautomerization of 4-21 
lead SAM left as a ylide, and the resulting radical delocalize on the porphyrin and 
induces the ring opening of the cyclopropyl group on porphyrin A ring to give 4-23, 
which can be quenched by abstracting a hydrogen atom from SAM (Figure 4.33). This 
can account for the deuterium incorporation of the porphyrin product when CD3-SAM 
was used. For pathway b, the early step is the same as the pathway a, which forms the 









































group on porphyrin B ring. The radical on 4-21 attacks back on the unsaturated bond of 
pyrrole to form a five-member ring on porphyrin B ring. Then 4-28b goes through a 
beta-scission to give the 4-29. Both 4-9 and 4-29 have the same mass and can be reduced 
under hydrogenation. NMR characterization of the enzymatic product will help to 
distinguish which ring is open. Since porphyrin with 18 π electron core is considered 
more stable than anaerobilin under light condition, it’s possible to purify compound 
using solid phase extraction followed by HPLC in a short amount of time. However, 
since the yield of enzymatic product is low and the purification steps under dark are 
tedious, there is not enough compound for NMR characterization yet. More compounds 
have to be purified in the future in order to obtain an NMR spectrum. Reference 
compounds 4-9 and 4-29 may also be made from irradiation of cyclopropyl 
protoporphyrin 4-12. 
As for the formation of SAM crosslinking species 4-10, 4-11, the early steps are 
the same as the formation of porphyrin product. However, after the SAM radical attacks 
the unsaturated bond of the porphyrin ring, instead of SAM leaving as ylide, the radical 
goes through β‐scission to cleave the porphyrin ring. The pyrrole racial 4-26 gets 
trapped by the ring opening of side chain cyclopropyl group. After tautomerization, 
SAM leaves as SAH. The resulting ring opening radical 4-27 can abstract a hydrogen 
atom from 5′-dA, which can again abstract a hydrogen atom from SAM. Then the SAM 
radical can attack the methylene group of the ring opening product 4-7, which further 
gets quenched by obtaining an electron and a proton to give the crosslinking species 4-




cyclopropyl protoporphyrin 4-12 was used as a substrate, and titanium citrate was used 
as a reducing agent, the intermediate SAM adduct 4-15 can be detected from the 
reduction of 4-26.  
 
 
Figure 4.33 Proposed mechanism 1 for how cyclopropyl heme substrate analog 4-6 trap 
radical intermediate by formation of porphyrin ring opening product in the ChuW 







































































Figure 4.34 Proposed mechanism 2 for how cyclopropyl heme substrate analog 4-6 trap 
radical intermediate by formation of porphyrin ring opening product in the ChuW 













































































Figure 4.35 Proposed mechanism for the formation of the crosslinking species in ChuW 
































































































































4.2.8. Proposed mechanisms for the ring opening product of ChuW catalyzed heme 
degradation 
Based on the previous results, cyclopropyl substrate analog studies and the 
proposed mechanism for NosN37-38, TbtI42, C10P41, a similar mechanism can be 
proposed for the heme degradation by ChuW (Figure 4.36). 
 
 




























































































Cyclopropyl heme analog was designed as a radical probe for ChuW catalyzed 
heme degradation. ChuW can take cyclopropyl heme analog as a substrate and several 
ring opening products were detected by LC-MS/MS, HPLC. A protoporphyrin ring 
opening product was further characterized by hydrogenation and is considered more 
stable for NMR characterization. However, there is no NMR spectrum currently 
available for this porphyrin compound, because the low yield of the enzymatic product 
and the potential light and air sensitivity of the compound. 
Similar as anaerobilin, porphyrin cleavage products are photolabile, including 
SAM anaerobilin adducts. The adducts were further confirmed by isotope labeling SAM 
studies. The cyclopropyl ring opening products and the SAM adducts suggested that a 
radical is generated on the porphyrin ring of heme by the attack of a SAM radical 
species. Based on the result, a mechanism was deduced for heme degradation by ChuW.  
4.4. Experimental methods 
4.4.1. Synthesis of cyclopropyl heme analog 
The overall scheme is shown in Figure 4.5. Each detailed step is shown as below: 
Synthesis of the protoporphyrin-IX dimethyl ester (4-3) 
The protoporphyrin-IX (100 mg) was added to a stirred solution of the trimethyl 
orthoformate (10 ml) and the methanol (10 ml). Concentrated sulfuric acid (1 ml) was 
then added slowly, with cooling to room temperature, and the solution was stirred at 
room temperature for 45 minutes. The mixture was then diluted with water, the pH was 




with dichloromethane. The organic extracts were washed with water and the solvent was 
removed under reduced pressure. The resulting solid was purified by column 
chromatography (silica gel, 20:1 CH2Cl2: MeOH) to give protoporphyrin-IX dimethyl 
ester. 1H NMR (400 MHz, Chloroform-d) δ 10.09 (d, J = 4.2 Hz, 2H), 9.97 (s, 2H), 8.24 
(m, 2H), 6.36 (d, J = 17.8 Hz, 2H), 6.19 (d, J = 11.5 Hz, 2H), 4.39 (t, J = 7.8 Hz, 4H), 
3.82 – 3.53 (m, 18H), 3.28 (t, J = 7.8 Hz, 4H). 
Synthesis of 3,8-di- [3' (R, S) -(1' -pyrazolinyl)]-deuteroporphyrin IX dimethyl ester 
(4-4) 
All reactions were carried out in the dark. A protective shield was used during 
diazomethane cycloaddition. The starting protoporphyrin-IX dimethyl ester (100 mg) 
was dissolved in dichloromethane (100 ml) and an ethereal solution of diazomethane (50 
ml) was added to the reaction mixture. The resulting solution was sealed with a rubber 
septum and kept at room temperature for 48 – 96 h. The solvent was degassed by 
bubbling with nitrogen and the resulting solution evaporated. The resulting solid was 
purified by column chromatography (silica gel, 100:1 - 10:1 CH2Cl2: acetone) to give 
3,8-di- [3' (R,S)-(1' -pyrazolinyl)]-deuteroporphyrin IX dimethyl ester. 1H NMR (400 
MHz, Chloroform-d) δ 10.05 (d, J = 21.4 Hz, 2H), 9.78 (dd, J = 34.3, 6.0 Hz, 2H), 7.03 – 
6.83 (m, 2H), 5.64 – 5.49 (m, 2H), 4.94 – 4.75 (m, 2H), 4.39 (td, J = 7.8, 3.2 Hz, 4H), 





Synthesis of 3,8-dicyclopropyldeuteroporphyrin IX dimethyl ester (4-5) 
The 8-di- [3' (R, S) -(1' -pyrazolinyl)]-deuteroporphyrin IX dimethyl ester (31 
mg) were dissolved in o-dichlorobenzene (20 ml) and heated at reflux for 45 min. The 
reaction solution was diluted with hexane (200 ml), and the formed residue was filtered 
and purified by column chromatography (silica gel, 100:1 CH2Cl2: acetone) to give the 
3,8-dicyclopropyldeuteroporphyrin IX dimethyl ester. 1H NMR (400 MHz, Chloroform-
d) δ 10.41 (d, J = 8.6 Hz, 2H), 10.03 (d, J = 10.0 Hz, 2H), 4.43 (m, 4H), 3.80 – 3.55 (m, 
18H), 3.32 (m, 4H), 3.14 – 3.01 (m, 2H), 1.70 (m, 4H), 1.54 – 1.44 (m, 4H). 
Synthesis of Ferric 3,8-dicyclopropyldeuteroporphyrin IX (4-6) 
Synthesis of ferric 3,8-dicyclopropyldeuteroporphyrin IX was followed a 
protocol to synthesize ferric meso-methylmesoheme regioisomers.84 The 3,8-
dicyclopropyldeuteroporphyrin IX dimethyl ester was hydrolyzed in 25% (v/v) HCl at 
25 °C in the dark for 8 h. The hydrolysis reaction was worked up by neutralizing to pH 
2-4, extracting with CH2Cl2, washing the organic phase with water before drying it with 
anhydrous Na2SO4, and removing the solvent under vacuum. The porphyrins were used 
without further purification for the subsequent reaction in which the iron was inserted by 
the ferrous sulfate method. An argon-purged, saturated aqueous Fe2SO4 solution (1mL) 
was added to a stirred, argon-purged solution of the porphyrins in 1 mL of pyridine and 
20 mL of acetic acid. The mixture was warmed for 10 min under a stream of argon. The 
stirred reaction mixture was then exposed to the air while it cooled to promote 
autooxidative formation of the ferric state before it was combined with 25 mL of brine 




unreacted porphyrin, washed with water, and dried over Na2SO4. Removal of the solvent 
under vacuum provided the ferric 3,8-dicyclopropyldeuteroporphyrin IX, which were 
purified by reversed-phase HPLC. HRMS m/z 644.2113, calculated for FeC36H36N4O4+ 
644.2080. lmax (CH2C12) 420, 540, 640 nm. 
4.4.2. Overexpression and purification of ChuW 
chuW was cloned into pTHT vector (modified from pET28b with TEV cleavage 
site). ChuW was over expressed in E. coli strain BL21 DE3 and was co-expressed with a 
plasmid encoding the suf operon. A 15 mL overnight culture was grown in LB medium 
in the presence of 40 µg/mL kanamycin and 30 µg/mL chloramphenicol. This was then 
added to 1.5 L of LB medium containing 40 µg/mL kanamycin and 30 µg/mL 
chloramphenicol. The cultures were incubated at 37°C with shaking (180 rpm) until the 
OD600 reached 0.45. The culture was then incubated at 4°C without shaking for 1 hour. 
Expression was induced by the addition of 100 µM IPTG followed by ferrous 
ammonium sulfate (120 mg) and cysteine (120 mg) and the culture was grown at 15 °C 
with shaking (110 rpm) overnight. The cells were harvested by centrifugation and stored 
in liquid nitrogen until further use. All steps for protein purification were carried out in 
an anaerobic chamber (COY laboratories). Cell pellets (~12 g) were thawed and 
resuspended in 30 mL lysis buffer (100 mM Tris-HCl, pH 7.5) in the presence of 
lysozyme (0.2 mg/mL) and benzonase (100 units). This mixture was cooled in an ice-
bath with continuous stirring for 1-2 hrs. The suspension was then sonicated to complete 
cell lysis for 5 × 120 s using a Misonix Sonicator XL-2000 (setting = 9). Cell debris was 




equilibrated with lysis buffer. The column was washed with 5-10 column volumes of 
wash buffer (100 mM Tris-HCl, 30 mM Imidazole, pH 7.5). The CysS protein was then 
eluted using elution buffer (100 mM Tris-HCl, 300 mM NaCl, 250 mM imidazole, pH 
7.5). The brown-colored fractions, containing the desired protein, were pooled and 
buffer exchanged to final buffer (100 mM Tris-HCl, pH 7.5 at 25 °C, 30% glycerol) 
using Econo-Pac 10DG size exclusion chromatography. The purified CysS was divided 
into aliquots in eppendorf tubes, frozen in liquid nitrogen, and stored at −80 °C, 
submerged in liquid nitrogen, until future use. Each tube has a pin hole in the cap to 
allow for gas release during thawing. Protein concentration was measured by the 
absorbance at 280 nm (A280) when the protein was exposed to air or the [4Fe-4S]2+ 
cluster was reduced to [4Fe-4S]1+ by dithionite (prevent the interference from 
absorbance from [4Fe-4S]2+) with an extinction coefficient calculated using the 
ProtParam tool of the ExPASy proteomics server.  
4.4.3. In vitro activity assay with ChuW: 
For the UV-Visible spectroscopy of monitoring ChuW activity, ChuW (5 µM) 
was incubated with 20 µM substrate and EcFld (5 µM) /EcFpr (2 µM), NADPH (200 
µM) reducing system anaerobically in dark. Assays were initiated by the addition of 
SAM (250 µM) and UV spectra were recorded every 10-20 minutes.  
For the HPLC and LCMS analysis of ChuW activity, 150 µM ChuW was 
incubated with 300 µM substrate, 1 mM SAM, 1 mM NADPH, 100 µM EcFld, and 50 
µM EcFpr in pH 7.5, 100 mM phosphate buffer anaerobically for 2.5 h at room 




equilibrated with 1 eq of methanol, 1 eq of H2O, and 1 eq of assay buffer. Once the assay 
mixture ran through the column, it was washed with 1eq of buffer,2 eq of water,1eq of 
1%TFA, and 3eq of water, before elution in 100% methanol in dark. The elution solution 
was further lyophilized before analyzed by HPLC and LCMS. 
4.4.4. HPLC parameters for the analysis of the ChuW reaction mixture 
HPLC analysis was performed on a ZORBAX Eclipse XDB-C18 column (15cm 
4.6mm, 5µm particles, Agilent Technologies, flow rate1⁄41mL/min). Typical injection 
volumes were in the range of 10–80µL. Data were processed using ChemStation ver. 
B.04.01 SP1 (Agilent Technologies).  
LC conditions: A- 0.1 % formic acid in H2O, B- 0.1 % formic acid in acetonitrile 
LC method: 0 min – 100% A, 2 min – 100% A, 4 min – 80% A 20% B, 27 min – 
100% B, 29 min – 100% B, 30 min – 100% A, 40 min – 100% A. 
4.4.5. LC-MS parameters for the analysis of the ChuW reaction mixture 
LC-ESI-TOF-MS on small molecules was performed using an Agilent 1260 
HPLC system equipped with a binary pump and a 1200 series diode array detector 
followed by a MicroToF-Q II mass spectrometer (Bruker Daltonics) using an ESI source 
in positive mode. The analysis was performed on a ZORBAX Eclipse XDB-C18 column 
(15 cm x 4.6 mm, 5 µm particles, Agilent).  
LC conditions: A- 5 mM Ammonium acetate buffer, pH 6.6, B- 75 % Methanol 
and 25 % Water. 
LC method: 0 min – 100% A, 2 min – 100% A, 4 min – 80% A 20% B, 27 min – 




5. TRAPPING A FOUR-CARBON FRAGMENT IN THIC CATALYZED 
REARRANGEMENT IN THIAMINE BIOSYNTHESIS  
5.1. Introduction 
Thiamine pyrophosphate (vitamin B1) is a crucial cofactor that is present in all 
living systems, in which it helps to catalyze essential biochemical reactions. Thiamine 
pyrophosphate is synthesized in the cytosol and is required in the cytosol for the activity 
of transketolase and in the mitochondria for the activities of pyruvate-, oxoglutarate-, 
branched chain keto acid dehydrogenases and thiamin acts as a stabilizer of an acyl 
carbanion biosynthon. The deficiency of thiamine in the diet will lead to the peripheral 
nervous system disease beriberi in human. 
In all organisms, the thiazole and pyrimidine moieties of thiamin monophosphate 
(ThMP) are generated in separate branches of the pathway and then joined by a coupling 
enzyme. The mechanisms of most enzymes in thiamin biosynthesis pathway are well 
understood.85-86 One of the exceptions is ThiC, a pyrimidine synthase in the thiamin 
biosynthetic pathways of bacteria and plants. 
ThiC catalyzes the complex rearrangement of aminoimidazole ribonucleotide 
(AIR) 5-1 to 4- amino-5-hydroxymethyl-2-methylpyrimidine phosphate (HMP-P) 5-2 
(Figure 5.1). The origin of all the atoms of the product and the fate of most of the atoms 





Figure 5.1 ThiC catalyzed rearrangement from AIR to HMP-P 
 
From the experimental data, we know that the proS hydrogen at C5′ is first 
abstracted by 5′-dA radical and then later replaced by a hydrogen atom from 5′-dA with 
retention of stereochemistry. The resulting 5′-dA radical has the second abstraction of a 
hydrogen atom from C4′ of AIR. C2′ of AIR becomes the methyl group C8 of HMP-P 
and C4′, C5′ remain in the HMP-P. C1′ of AIR is released as formate and C3′ is lost as 
carbon monoxide. N5 of AIR is retained as the N4 of the HMP-P. C3′ hydrogen of AIR 
is transferred to C8 of HMP-P while C2′ hydrogen remains in the C8 of HMP-P. One 
hydrogen on C8 and the hydrogen on C6 of HMP-P are from the solvent.  
Based on the current data, a mechanism for ThiC catalyzed rearrangement can be 
proposed (Figure 5.2). The 5′-dA radical first abstracts a hydrogen atom from C5′ of 
AIR. The resulting radical goes through a beta scission and then a reduction by the 
amino imidazole to give 5-5. The radical on the amino imidazole induces the cleavage of 
the N-glycosyl bond. Then the amino imidazole is reoriented in the active site to add on 














































radical further abstracts a hydrogen atom from C4′. Cyclization and hydrogen atom 
transfer of the resulting radical give 5-13. Then, C1′ leaves as formate to form the radical 
stabilized carbanion 5-14. After protonation, the C3′ radical goes through a 
ribonucleotide reductase type of dehydration to form  a-keto radical 5-16. Similar as the 
Dowd–Beckwith ring-expansion reaction, another cyclization gives bicyclic intermediate 
5-17 followed by two beta scission and oxidation to give acylium ion 5-19. CO 
elimination and tautomerization give the final product HMP-P 5-2. 
A ThiC paralog, BzaF, can catalyze the conversion of AIR to 
hydroxybenzimidazole – one form of the axial ligands of vitamin B12. Labeling studies 
have established that the early steps in the ThiC and BzaF-catalyzed reactions are same. 
EPR studies on BzaF using AIR isotopologues show a transient radical with a structure 
that is consistent with intermediate 5-5.89 Since desamino-AIR is not a substrate for 
ThiC, the amino group may play a role for in activating the substrate for the electron 





Figure 5.2 Proposed mechanism for ThiC catalyzed AIR 5-1 to HMP-P 5-2 
rearrangement.  
 
Compared with the canonical CX3CX2C cluster-binding motif for radical SAM 
enzyme, ThiC adopts an unusual CX2CX4C motif for the iron-sulfur cluster binding. 













































































































































































5-1 5-3 5-4 5-5
5-6 5-7 5-8 5-9
5-10 5-11 5-12 5-13
5-14 5-15 5-16 5-17 5-18




5′-dA, methionine, AIR, imidazole ribonucleotide) are available. These structures not 
only reveal a novel second iron site involved in amino acid binding but also give an 
insight into possible protein residues in the active site that may involve in the catalysis. 
The active D383N mutant suggests that the N-glycosyl bond cleavage is not strongly 
dependent on acid catalysis. Several other mutants (D383N, M248L, C474S and H417A) 
still needs further investigation. 
Although the activity of ThiC was reconstituted in vitro more than ten years 
ago,87 we still don’t know most of the steps in the mechanism because of the low activity 
and narrow range of substrates tolerance. While we tried to identify the new products 
and metabolites in ThiC mutants, a four-carbon fragment from AIR was detected during 
ThiC catalyzed reaction.  
5.2. Result and discussion 
5.2.1. Identification of bound metabolites co-purifying with ThiC 
When wild-type ThiC (wtThiC), recombinantly over-expressed in E. coli in LB 
medium and purified in a glove box, several bound metabolites were detected by HPLC 
under UV of 250 nm after ThiC was heat denatured (Figure 5.3). By comparing with the 
UV and the retention time of the standard, around 4 min peak is identified as SAM and 
around 17 min peak as 5′-dA. After the treatment of alkaline phosphatase from calf 
intestinal (CIP), the early retention time peaks were disappeared or decreased with the 
increase of 16 min peak and appearance of a new peak around 15 min. For the ThiC 




more peak around 2 min, which disappeared under CIP treatment with the formation of a 
new peak around 14 min (Figure 5.4).  
 
 
Figure 5.3 HPLC analysis of bound metabolites in ThiC under 250 nm. UV spectrum of 




























Figure 5.4 HPLC analysis of bound metabolites in the ThiC mutant C474S under 250 
nm. UV spectrum of different bound metabolites metabolites. 
 
Based on the UV similarity and co-elution studies of the bound metabolites with 
different nucleosides, the 17 min peak is identified as adenosine (Figure 5.5). The 15 
min peak is identified as deoxyguanosine. The 14 min peak is identified as guanosine. 

























Figure 5.5 Upper panel: UV spectrum of guanosine and adenosine. Middle panel:  co-
elution HPLC traces of bound metabolites in the ThiC mutant C474S and guanosine, 
adenosine under 250 nm. Lower panel: co-elution HPLC traces of bound metabolites in 












































5.2.2. Detection of a four-carbon fragment in ThiC reaction by LC-MS/MS 
When Arabidopsis thaliana ThiC (AtThiC) was incubated with AIR, SAM, 
dithionite in an anaerobic condition, a new peak with a mass of 204.10 was detected by 
LC-MS/MS after heat quenching (Figure 5.6). This peak only presents in the full 
reaction and is absent in all other controls. By using isotope labeling AIR substrates, it 
was found that four carbons from the ribose part of the AIR but not the nitrogen of the 
amino group and C1′ of AIR were incorporated in this new compound (Figure 5.7).  
 
Figure 5.6 LC-MS analysis of ThiC catalyzed AIR to HMP rearrangement. Upper panel: 
EICs of 5′-dA [M+H]+ (204.10±0.02). Lower panel: mass spectrum of 204 compound at 
14 min.  
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Figure 5.7 Isotope labeling pattern in 204.10 shunt product in ThiC catalyzed reaction. 
Mass spectrum of the in 204.10 compound when the substrate is (A) 2′-13C-AIR; (B) 






























































































































































Figure 5.7 Isotope labeling pattern in 204.10 shunt product in ThiC catalyzed reaction. 
Mass spectrum of the in 204.10 compound when the substrate is (A) 2′-13C-AIR; (B) 





































































































5.2.3. Identification of the methionine as the trapping agent for the four-carbon 
fragment of the AIR 
When CD3-SAM was used in the reaction, there was an increase of three mass 
units in the mass of 204.10 peak. Similarly, when 13CH3-SAM was used as the cofactor, 
there was an increase of one mass in the mass of 204.10 peak (Figure 5.8). Considered 
the error range of the mass instrument we used, the error of the measured mass and the 
exact mass should be less than 10 ppm. Based on the reactants in ThiC reaction, one of 
the most possible chemical formula of 204.1048 contains a sulfur atom. These results 
lead us to think the sulfur as well as the methyl group of SAM could be incorporated into 














Figure 5.8 Isotope labeling pattern in 204.10 compound from different isotope labeling 
SAM. Mass spectrum of the in 204.10 compound when (Upper panel) CD3-SAM; 
(Lower panel) 13CH3-SAM. 
 
In order to explore whether the other parts of SAM were incorporated in this 
204.10 peak, different labeling SAM was biosynthesized. When (adenosyl-13C10)-SAM 
was used as the cofactor in ThiC reaction, the mass of byproduct peak remained the 
same, which suggested that the adenosyl part of SAM was not incorporated into this 
compound (Figure 5.9). However, when (methionine-D8)-SAM was used in the reaction, 












































Figure 5.9 Isotope labeling pattern in 204.10 compound from different isotope labeling 
SAM. Mass spectrum of the in 204.10 compound when different isotope labeling SAM 
was used in the ThiC catalyzed reaction. Upper panel: (adenosyl-13C10)-SAM; Lower 
panel: (methionine-D8)-SAM. 
 
To further explore whether the methionine in the 204.10 peak comes from SAM, 
fivefold excess of D8-methionine (compared with the concentration of SAM) was 
incubated in the ThiC reaction. LC-MS analysis of the reaction mixture revealed that 
more than 80% of the product was deuterium labeled (212.15) (Figure 5.10). This 
suggests that methionine part that gets incorporated into the peak does not have to come 





















































































Figure 5.10 Isotope labeling pattern in 204.10 compound when excess of D8-methionine 
was added to the ThiC catalyzed reaction. 
 
In order to probe whether the AIR fragments trapped by methionine happened in 
the enzyme active site, D-methionine, L-methionine, cysteine, L-homocysteine were also 
incubated with the ThiC reaction respectively. Only D/L-methionine showed the 
incorporation in the unknown compound, while there is no much difference between D-
methionine or L-methionine.  
5.2.4. Determination of possible reference compounds for the detected shunt 
product in ThiC catalyzed reaction 
Based on the experimental data in section 5.2.2-5.2.4, the shunt product consists 
of four carbon atoms (2′,3′,4′,5′) from AIR substrate and methionine from SAM or 
buffer. It’s not known how the four-carbon fragment is connected to the methionine. 
Based on the ThiC proposed mechanism, the crystal structure and the electrophilic 
property of the atoms in methionine, the most possible structure of the shunt product is 
the sulfonium compounds 5-21, where the four-carbon is linked to methionine through 
the sulfur atom (Figure 5.11). In one of the conformation in ThiC, the distance between 





































Figure 5.11 Possible structures for the shunt product.  
 
 
Figure 5.12 The distance between sulfur atom of SAH and the 5′C of the AIR in ThiC 












Based on the analysis of MS/MS fragments of the shunt product, it is also 
possible that the four-carbon is linked to methionine through the nitrogen atom of the 
methionine (Figure 5.13, 5.15). Compounds 5-22a and 5-22b were synthesized. 
However, from the retention time and MS/MS fragments of these compounds, neither of 
them match the enzymatic shunt product generated in the ThiC catalyzed reaction. It’s 
possible that 5-21 can have an arrangement to form 5-22, which gives the observed 
MS/MS fragmentations. 
Figure 5.13 Mass fragmentation of the shunt product (204.1053) when ThiC catalyzed 











































































































Figure 5.15 Mass fragmentation of the shunt product (204.1053) in ThiC catalyzed 








































































Figure 5.15 Mass fragmentation of the shunt product (204.1053) in ThiC catalyzed 
reaction when substrate is (A) 2′-13C-AIR; (B) 1′,2′,3′,4′,5′-13C5-AIR; (C) 4′-2H-AIR. 
 
5.3. Conclusion 
By using high resolution LC-MS, isotope labeling AIR, SAM and methionine, a 
four-carbon fragment and methionine adduct was detected. Since the adduct does not 
have a structure like compounds 5-22. It’s possible that the shunt product has structures 
like compounds 5-21. From the isotope labeling studies, we learn that this four-carbons 
fragment forms after 5′-dA abstracts a hydrogen atom from the C5′ of the AIR but before 
the second hydrogen abstraction from C4′ of the AIR. Also, it forms after the C1′ release 
as formate and before imidazole recombines with the sugar backbone or the imidazole 
gets hydrolyzed after recombines with the sugar backbone. If it’s not the latter case, it 




























5.4. Experimental methods 
5.4.1. Overexpression and purification of AtThiC 
ΔN71-AtThiC in pET-28 plasmid was transformed into E. coli BL21(DE3) cells. 
ThiC was over expressed in E. coli BL21 DE3 and was co-expressed with a plasmid 
encoding the suf operon. A 15 mL overnight culture was grown in LB medium in the 
presence of 40 µg/mL kanamycin and 30 µg/mL chloramphenicol. This was then added 
to 1.5 L of LB medium containing 40 µg/mL kanamycin and 30 µg/mL 
chloramphenicol. The cultures were incubated at 37°C with shaking (180 rpm) until the 
OD600 reached 0.45. The culture was then incubated at 4°C without shaking for 1 hour. 
Expression was induced by the addition of 100 µM IPTG followed by ferrous 
ammonium sulfate (120 mg) and cysteine (120 mg) and the culture was grown at 15°C 
with shaking (110 rpm) overnight. The cells were harvested by centrifugation and stored 
in liquid nitrogen until further use. All steps for protein purification were carried out in 
an anaerobic chamber (COY laboratories). Cell pellets (~12 g) were thawed and 
resuspended in 30 mL lysis buffer (100 mM Tris-HCl, pH 7.5) in the presence of 
lysozyme (0.2 mg/mL) and benzonase (100 units). This mixture was cooled in an ice-
bath with continuous stirring for 1-2 hrs. The suspension was then sonicated to complete 
cell lysis for 5 × 120 s using a Misonix Sonicator XL-2000 (setting = 9). Cell debris was 
removed by centrifugation, and the lysate was loaded onto a Histrap column pre-
equilibrated with lysis buffer. The column was washed with 5-10 column volumes of 
wash buffer (100 mM Tris-HCl, 30 mM Imidazole, pH 7.5). The CysS protein was then 
eluted using elution buffer (100 mM Tris-HCl, 300 mM NaCl, 250 mM imidazole, pH 
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7.5). The brown-colored fractions, containing the desired protein, were pooled and 
buffer exchanged to final buffer (100 mM Tris-HCl, pH 7.5 at 25 °C, 30% glycerol) 
using Econo-Pac 10DG size exclusion chromatography. The purified ThiC was divided 
into aliquots in eppendorf tubes, frozen in liquid nitrogen, and stored at −80 °C, 
submerged in liquid nitrogen, until future use. Protein concentration was measured by 
the absorbance at 280 nm (A280) with an extinction coefficient calculated using the 
ProtParam tool of the ExPASy proteomics server.  
5.4.2. Enzymatic synthesis of AIR from AIRs: 
A typical reaction mixture consisted of 25 µL 100 mM AIRs, 10 µL 400 mM 
ATP, 5 µL 1 M MgCl2, 900 µL 25 mM KPi (pH 7.5) and 100 µL of the AIRs kinase 
stock.   
The reaction mixture was allowed to incubate at room temperature for 1 hr and 
was lyophilized till dry. The residue was transferred into the glove box and resuspended 
in degassed water to a final volume of 100 µL (final AIR concentration of ~25 mM). 
This AIR stock was directly used for ThiC reactions.  
5.4.3. Enzymatic assay of ThiC reaction 
A typical enzymatic reaction was performed in 100 mM phosphate buffer, pH 7.5 
containing 250 µM ThiC, 1 Mm AIR, 1.2 mM  SAM and 5 mM dithionite.  The reaction 
was incubated at room temperature anaerobically for 2 hours. EcFld (5 µM) /EcFpr (2 
µM), NADPH (200 µM) reducing system anaerobically in dark. For HPLC, LC-MS 
analysis, the enzymatic reaction was heat quenched at 90 °C for two minutes and then 




5.4.4. Alkaline phosphate treatment of ThiC reaction 
Alkaline phosphatase 1µL (1000 units) was added to 100 µl to 200 µl of ThiC 
enzymatic reaction. The mixture was incubated at 37°C for 30 minutes and then 
quenched through 10kDa cut-off filter before it was analyzed by HPLC or LC-MS. 
5.4.5. HPLC parameters for the analysis of the ThiC reaction mixture 
HPLC analysis was performed on a ZORBAX Eclipse XDB-C18 column (15cm 
4.6mm, 5µm particles, Agilent Technologies, flow rate1 mL/min). Typical injection 
volumes were in the range of 10–80µL. Data were processed using ChemStation ver. 
B.04.01 SP1 (Agilent Technologies).  
HPLC conditions: (Flow rate 1mL/min) 
A. Water. 
B. 100 mM potassium 
acetate, pH 6.6. C. Methanol. 
phosphate 
buffer, pH 
6.6/10 mM ammonium 
HPLC method: 
0min—100% B, 5min—100% B, 14min—7% A 70% B 23% C, 25min—25% A 
0% B 75% C, 28min—25% A 0% B 75% C, 32min—100% B, 36min—100% B. 
5.4.6. LC-MS parameters for the analysis of the ThiC reaction mixture 
LC-ESI-TOF-MS on small molecules was performed using an Agilent 1260 
HPLC system equipped with a binary pump and a 1200 series diode array detector 
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followed by a MicroToF-Q II mass spectrometer (Bruker Daltonics) using an ESI source 
in positive mode. The analysis was performed on a ZORBAX Eclipse XDB-C18 column 
(15 cm x 4.6 mm, 5 µm particles, Agilent).  
LC conditions: A- 5 mM Ammonium acetate buffer, pH 6.6, B- 75 % Methanol 
and 25 % Water. 
LC method: 0 min – 100% A, 2 min – 100% A, 4 min – 80% A 20% B, 27 min – 
100% B, 29 min – 100% B, 30 min – 100% A, 40 min – 100% A. 
6. SUMMARY AND OUTLOOK
6.1. Summary 
Here, we have explored unusual reactions catalyzed by radical SAM enzymes. In 
cystobactamid biosynthesis, CysS utilizes B12, SAM and [4Fe-4S] to perform sequential 
methylations on an sp3-hybridized carbon. In anaerobic heme degradation pathway, 
ChuW not only methylates the porphyrin ring but also cleaves the ring to release the 
iron. In thiamin biosynthesis pathway, ThiC catalyzes the most complicated 
rearrangement from AIR to HMP-P. In the first two cases, classic probes (radical trap, 
isotope labeling compounds) were designed to trap the unstable intermediates to study 
the detailed mechanism or conformations in the enzyme active site. For the last case, 
because of the narrow substrates tolerance of the ThiC and the lack of chromophore in 
the substrate, it’s harder to use substrate analogs to study the mechanism. Here, we are 
able to trap a four-carbon fragmentation from AIR by methionine using unbiased LC-
MS/MS analysis and isotope labeling approaches. These give us a better insight into how 
nature uses complex protein architecture and inherent chemistry property of substrates to 
perform novel reactions.  
6.2. Outlook 
6.2.1. B12 dependent radical SAM methyltransferase-CysS 
6.2.1.1. Crystallography 
Currently, there is no crystal structure that is published for the B12 dependent 
radical SAM methyltransferase. However, there is a crystal structure for a B12-dependent 
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radical SAM enzyme, OxsB, which performs a ring contraction reaction to generate 
oxetanocin A. Although no substrate or product is bound to the crystal, cobalamin, 
SAM, [4Fe-4S] cluster are found in the crystal, which gives us insight into how a B12-
dependent radical SAM transferase could position the SAM and Cbl to perform both 
racial reaction and methyl transfer. Bridwell-Rabb was able to obtain two conformations 
of SAM binding to the unique Fe of the [4Fe-4S] cluster.22 In one of the conformation,
the S atom of SAM is 3.0 Å to the unique Fe, which is in the range (3.4 Å) that is 
permitted for reductive cleavage of SAM while the methyl group of the SAM is 8.8 Å
from Co of Cbl. In another conformation, the S atom of SAM is 6.5 Å to the unique Fe 
while the methyl group of the SAM is 5.8 Å from Co of Cbl, which favors the methyl
transfer reaction to the Cbl. In this case, it seems SAM can both initiate the radical 
chemistry and perform the methyl transfer in the same active site. Nevertheless, OxsB is 
not a methyltransferase. It’s not clear why SAM adopt two conformations to perform the 
ring contraction and why Cbl is needed. CysS has a sequence similarity around 16% 
with OxsB and mostly align in the Cbl-binding domain and SAM radical domain. 
Compared to the OxsB, CysS lacks the N-terminal domain of OxsB and has great 
variation in the C-terminal helix bundle of OxsB, which is proposed for the 
conformational change upon the binding of the substrate. We have made several 
constructs and substrate analogs for the crystallography of CysS and the study is still in 
progress. It will be interesting to see whether CysS adopts similar conformations for 
SAM to achieve the unusual methylation with Cbl.  
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6.2.1.2. The evolution of radical SAM enzymes 
Currently, the radical SAM superfamily contains 113,000 unique sequences that 
represent more than 65 distinct reactions across all domains of life. The catalytic 
activities of radical SAM enzymes are usually low compared to other highly efficient 
enzymes. SAM is not always used as a cofactor instead is consumed as a substrate for 
many reactions catalyzed by radical SAM enzymes. Both [4Fe-4S] cluster and SAM are 
not complicated cofactors in the living organism. Therefore, the radical SAM enzymes 
are considered as ancient enzymes instead of well evolved modern enzymes, especially 
for their capability to mediate radical reactions under anaerobic condition. 
Adenosylcobalamin (AdoCbl)-dependent enzymes also catalyze unusual 
rearrangement or elimination reactions through radical chemistry. The catalytic cycle 
starts with the homolytic cleavage of the Co–C bond to generated the 5′-dA radical, 
which abstracts a hydrogen atom from a substrate. The substrate radical can undergo 
rearrangement and subsequent hydrogen exchange to yield the final product.90 Most of 
the radical SAM enzymes also use 5′-dA radicals to initiate the reaction. However, The 
C–Co bond of AdoCbl is around 30 kcal/mol while the 5′-C-S bond of SAM is around 
60 kcal/mol. Also, in order to cleave SAM, there must be a one-electron reduction step. 
Considered SAM is not as a chemically elegant molecule as adenosylcobalamin, SAM is 
regarded as “a poor man’s adenosylcobalamin.91 However, in terms of the number of the 
enzymes and reaction diversity, the radical SAM enzymes far exceed of the AdoCbl-
dependent enzymes. There are only 12 groups of AdoCbl-dependent enzymes have so 




Furthermore, it takes nearly 30 enzymatic steps to biosynthesize cobalamin while SAM 
only requires one step by methionine adenosyltransferase using methionine and ATP. 
From these aspects, it’s possible that AdoCbl-dependent enzymes evolve from radical 
SAM enzymes. 
Cobalamin-dependent radical SAM enzymes are a large class of enzymes that 
use both radical SAM machinery and cobalamin to catalyze unusual reactions, such as 
inactive carbon methylation, phosphorous atoms methylation, ring contraction. From the 
crystal structure of OxsB, we know that SAM bound [4Fe-4S] cluster and Cbl are just 4 
Å apart, which indicates that it’s quite conceivable that same substrate can bind to a 
single position and react with two cofactors in a single active site. This active site 
combines both SAM radical core unit and Cbl-binding Rossmann domain. It’s proposed 
that OxsB can be considered as a radical SAM enzyme that has been adapted to bind 
Cbl.92 It’s likely that cobalamin-dependent radical SAM enzyme is an ancient ancestry 
of the AdoCbl-dependent enzyme. 
From the mechanistic studies of CysS, we learn that the enzyme prefers Cbl(II) 
to start with and 5′-dA radical can be generated by reductive cleavage of radical SAM 
enzyme. With a close vicinity of Cbl(II) and a 5′-dA radical, it’s interesting to speculate 
the possibility of generating the AdoCbl, which could be a random event for the first 







6.2.2. ChuW in anaerobic heme degradation pathway 
ChuW has high sequence similarity with HemN. HemN is a radical SAM enzyme 
that catalyzes the oxidative decarboxylation of the propionate side chains of rings A and 
B of coproporphyrinogen III to form protoporphyrinogen IX. It is shown that EPR can 
be used to detect a comparatively stable delocalized substrate radical intermediate.93 
Here for ChuW, we are able to use a cyclopropyl heme analog to trap a radical 
intermediate on the porphyrin ring by forming stable porphyrin compound and SAM 
adducts. It’s conceivable that we can directly use EPR to detect the possible radical 
intermediate in the ChuW catalyzed cyclopropyl heme analog reaction. 
ChuW is assigned as the class C radical SAM enzyme. NosN, another enzyme in 
this family, catalyzes both carbon transfer from SAM and formation of the ester linkage 
between Glu6 and the appended C4 carbon unit of 3,4-dimethylindolic acid (DMIA) 
motif in nosiheptide biosynthesis.38 It is shown that NosN can cleave an allyl analog of 
SAM (allyl-SAM) efficiently and the resulting 5′-dA radical can be captured by the 
olefin moieties of allyl-SAM or 5′-allylthioadenosine (ATA).94 It’s possible that ChuW 
can also take allyl-SAM as a substrate and the resulting product may provide insight of 
whether 5′-dA radical abstracts a hydrogen atom from SAM or methylthioadenosine, and 
the orientation of two SAM molecules in the active site. It will also be useful to get a 







6.2.3. HMP-P synthase ThiC in thiamin pyrimidine biosynthesis  
6.2.3.1. Formation of the four-carbon fragment with methionine 
From the structure characterization of the four-carbon fragment, we know that all 
the oxygen is lost in this shunt product. It will be useful to know whether the reducing 
agent- dithionite used for the ThiC reaction is strong enough to reduce the leaking 
intermediate to form the four-carbon fragment or the two oxygen indeed is lost during 
the enzymatic reaction. If it’s the latter case, the oxygen of the by-product carbon 
monoxide in the ThiC catalyzed reaction should come from water instead of oxygen 
from the AIR. We can try to obtain the isotope pattern of oxygen of carbon monoxide in 
ThiC reaction under D2O condition by GC-MS. 
6.2.3.2. The function of the mononuclear metal center in ThiC 
Compare to other classic radical SAM enzymes, ThiC not only has a different 
binding mode for SAM but also have an extra Fe/Zn binding site. It will be interesting to 
know whether Fe is the actual metal that function in ThiC and whether it has a redox role 
in catalyzing the reaction. Also, the ThiC crystal structure has shown the amino and 
carboxylate group of methionine are coordinated with the metal. The metal may also 
play a role in trapping the four-carbon fragment with methionine. Mutants study of the 
ligands (H417A, H481A) on the effect of the formation of the four-carbon fragment with 
methionine will give some hints about how the four-carbon fragment forms. 
6.2.3.3. ThiC mutants’ studies 
Besides H417A and H481A in Caulobacter crescentus ThiC (CcThiC), other 




abstracts a hydrogen atom from AIR, which suggests the radical chemistry is initiated. 
Potential intermediate can be trapped by radical probes for these mutants. 
6.2.3.4. Substrate analogs studies  
In the proposed mechanism for ThiC catalyzed rearrangement, there is a 
dehydration reaction induced by the radical, which is similar to the case in 
ribonucleotide reductase (RNR) for the step 5-14 to 5-16 in Figure 5.2. There have been 
extensive substrate analogs studies for RNR. Similar strategy can also be applied to 
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